[{"arc":[[52.421459197998,-1.43792998790741],[25.8990993499756,45.3538589477539]],"countries":["United Kingdom","Saudi Arabia"],"title":"Frequency and clinical relevance of human bocavirus infection in acute exacerbations of chronic obstructive pulmonary disease"},{"arc":[[57.0153617858887,9.98657989501953],[56.1693496704102,10.1982297897339]],"countries":["Denmark"],"title":"Proteomic Analysis of the Vitreous following Experimental Retinal Detachment in Rabbits"},{"arc":[[57.0153617858887,9.98657989501953],[46.72547,-116.99277]],"countries":["Denmark","United States"],"title":"Proteomic Analysis of the Vitreous following Experimental Retinal Detachment in Rabbits"},{"arc":[[57.0153617858887,9.98657989501953],[37.8056831359863,-122.268104553223]],"countries":["Denmark","United States"],"title":"Proteomic Analysis of the Vitreous following Experimental Retinal Detachment in Rabbits"},{"arc":[[57.0153617858887,9.98657989501953],[55.6756706237793,12.5675601959229]],"countries":["Denmark"],"title":"Proteomic Analysis of the Vitreous following Experimental Retinal Detachment in Rabbits"},{"arc":[[56.1693496704102,10.1982297897339],[46.72547,-116.99277]],"countries":["Denmark","United States"],"title":"Proteomic Analysis of the Vitreous following Experimental Retinal Detachment in Rabbits"},{"arc":[[56.1693496704102,10.1982297897339],[37.8056831359863,-122.268104553223]],"countries":["Denmark","United States"],"title":"Proteomic Analysis of the Vitreous following Experimental Retinal Detachment in Rabbits"},{"arc":[[56.1693496704102,10.1982297897339],[55.6756706237793,12.5675601959229]],"countries":["Denmark"],"title":"Proteomic Analysis of the Vitreous following Experimental Retinal Detachment in Rabbits"},{"arc":[[46.72547,-116.99277],[37.8056831359863,-122.268104553223]],"countries":["United States"],"title":"Proteomic Analysis of the Vitreous following Experimental Retinal Detachment in Rabbits"},{"arc":[[46.72547,-116.99277],[55.6756706237793,12.5675601959229]],"countries":["Denmark","United States"],"title":"Proteomic Analysis of the Vitreous following Experimental Retinal Detachment in Rabbits"},{"arc":[[37.8056831359863,-122.268104553223],[55.6756706237793,12.5675601959229]],"countries":["Denmark","United States"],"title":"Proteomic Analysis of the Vitreous following Experimental Retinal Detachment in Rabbits"},{"arc":[[40.5150184631348,20.8693809509277],[34.7472496032715,113.624931335449]],"countries":["Albania","China"],"title":"Nonstructural Protein 5A Is Incorporated into Hepatitis C Virus Low-Density Particle through Interaction with Core Protein and Microtubules during Intracellular Transport"},{"arc":[[40.5150184631348,20.8693809509277],[35.7130813598633,139.445846557617]],"countries":["Albania","Japan"],"title":"Nonstructural Protein 5A Is Incorporated into Hepatitis C Virus Low-Density Particle through Interaction with Core Protein and Microtubules during Intracellular Transport"},{"arc":[[34.7472496032715,113.624931335449],[35.7130813598633,139.445846557617]],"countries":["China","Japan"],"title":"Nonstructural Protein 5A Is Incorporated into Hepatitis C Virus Low-Density Particle through Interaction with Core Protein and Microtubules during Intracellular Transport"},{"arc":[[40.9437103271484,40.2619209289551],[31.2988891601562,121.499168395996]],"countries":["Turkey","China"],"title":"Subclinical in utero Zika virus infection is associated with interferon alpha sequelae and sex-specific molecular brain pathology in asymptomatic porcine offspring"},{"arc":[[40.9437103271484,40.2619209289551],[-20.8712291717529,144.602111816406]],"countries":["Turkey","Australia"],"title":"Subclinical in utero Zika virus infection is associated with interferon alpha sequelae and sex-specific molecular brain pathology in asymptomatic porcine offspring"},{"arc":[[40.9437103271484,40.2619209289551],[46.7798385620117,-71.2695007324219]],"countries":["Turkey","Canada"],"title":"Subclinical in utero Zika virus infection is associated with interferon alpha sequelae and sex-specific molecular brain pathology in asymptomatic porcine offspring"},{"arc":[[40.9437103271484,40.2619209289551],[49.8096008300781,-97.1333312988281]],"countries":["Turkey","Canada"],"title":"Subclinical in utero Zika virus infection is associated with interferon alpha sequelae and sex-specific molecular brain pathology in asymptomatic porcine offspring"},{"arc":[[40.9437103271484,40.2619209289551],[52.1374397277832,-106.627517700195]],"countries":["Turkey","Canada"],"title":"Subclinical in utero Zika virus infection is associated with interferon alpha sequelae and sex-specific molecular brain pathology in asymptomatic porcine offspring"},{"arc":[[40.9437103271484,40.2619209289551],[52.08896,5.1784]],"countries":["Turkey","Netherlands"],"title":"Subclinical in utero Zika virus infection is associated with interferon alpha sequelae and sex-specific molecular brain pathology in asymptomatic porcine offspring"},{"arc":[[31.2988891601562,121.499168395996],[-20.8712291717529,144.602111816406]],"countries":["China","Australia"],"title":"Subclinical in utero Zika virus infection is associated with interferon alpha sequelae and sex-specific molecular brain pathology in asymptomatic porcine offspring"},{"arc":[[31.2988891601562,121.499168395996],[46.7798385620117,-71.2695007324219]],"countries":["China","Canada"],"title":"Subclinical in utero Zika virus infection is associated with interferon alpha sequelae and sex-specific molecular brain pathology in asymptomatic porcine offspring"},{"arc":[[31.2988891601562,121.499168395996],[49.8096008300781,-97.1333312988281]],"countries":["China","Canada"],"title":"Subclinical in utero Zika virus infection is associated with interferon alpha sequelae and sex-specific molecular brain pathology in asymptomatic porcine offspring"},{"arc":[[31.2988891601562,121.499168395996],[52.1374397277832,-106.627517700195]],"countries":["China","Canada"],"title":"Subclinical in utero Zika virus infection is associated with interferon alpha sequelae and sex-specific molecular brain pathology in asymptomatic porcine offspring"},{"arc":[[31.2988891601562,121.499168395996],[52.08896,5.1784]],"countries":["China","Netherlands"],"title":"Subclinical in utero Zika virus infection is associated with interferon alpha sequelae and sex-specific molecular brain pathology in asymptomatic porcine offspring"},{"arc":[[-20.8712291717529,144.602111816406],[46.7798385620117,-71.2695007324219]],"countries":["Canada","Australia"],"title":"Subclinical in utero Zika virus infection is associated with interferon alpha sequelae and sex-specific molecular brain pathology in asymptomatic porcine offspring"},{"arc":[[-20.8712291717529,144.602111816406],[49.8096008300781,-97.1333312988281]],"countries":["Australia","Canada"],"title":"Subclinical in utero Zika virus infection is associated with interferon alpha sequelae and sex-specific molecular brain pathology in asymptomatic porcine offspring"},{"arc":[[-20.8712291717529,144.602111816406],[52.1374397277832,-106.627517700195]],"countries":["Australia","Canada"],"title":"Subclinical in utero Zika virus infection is associated with interferon alpha sequelae and sex-specific molecular brain pathology in asymptomatic porcine offspring"},{"arc":[[-20.8712291717529,144.602111816406],[52.08896,5.1784]],"countries":["Australia","Netherlands"],"title":"Subclinical in utero Zika virus infection is associated with interferon alpha sequelae and sex-specific molecular brain pathology in asymptomatic porcine offspring"},{"arc":[[46.7798385620117,-71.2695007324219],[49.8096008300781,-97.1333312988281]],"countries":["Canada"],"title":"Subclinical in utero Zika virus infection is associated with interferon alpha sequelae and sex-specific molecular brain pathology in asymptomatic porcine offspring"},{"arc":[[46.7798385620117,-71.2695007324219],[52.1374397277832,-106.627517700195]],"countries":["Canada"],"title":"Subclinical in utero Zika virus infection is associated with interferon alpha sequelae and sex-specific molecular brain pathology in asymptomatic porcine offspring"},{"arc":[[46.7798385620117,-71.2695007324219],[52.08896,5.1784]],"countries":["Canada","Netherlands"],"title":"Subclinical in utero Zika virus infection is associated with interferon alpha sequelae and sex-specific molecular brain pathology in asymptomatic porcine offspring"},{"arc":[[49.8096008300781,-97.1333312988281],[52.1374397277832,-106.627517700195]],"countries":["Canada"],"title":"Subclinical in utero Zika virus infection is associated with interferon alpha sequelae and sex-specific molecular brain pathology in asymptomatic porcine offspring"},{"arc":[[49.8096008300781,-97.1333312988281],[52.08896,5.1784]],"countries":["Canada","Netherlands"],"title":"Subclinical in utero Zika virus infection is associated with interferon alpha sequelae and sex-specific molecular brain pathology in asymptomatic porcine offspring"},{"arc":[[52.1374397277832,-106.627517700195],[52.08896,5.1784]],"countries":["Canada","Netherlands"],"title":"Subclinical in utero Zika virus infection is associated with interferon alpha sequelae and sex-specific molecular brain pathology in asymptomatic porcine offspring"},{"arc":[[40.9437103271484,40.2619209289551],[23.1290798187256,113.264358520508]],"countries":["Turkey","China"],"title":"Epidemiology and clinical characteristics of human coronaviruses OC43, 229E, NL63, and HKU1: a study of hospitalized children with acute respiratory tract infection in Guangzhou, China"},{"arc":[[41.0080909729004,29.0522594451904],[37.7697296142578,-122.466094970703]],"countries":["United States","Turkey"],"title":"a section of the journal Frontiers in Microbiology Comparative Analysis of Salivary Gland Proteomes of Two Glossina Species that Exhibit Differential Hytrosavirus Pathologies"},{"arc":[[41.0080909729004,29.0522594451904],[20.2663593292236,85.8105697631836]],"countries":["Turkey","India"],"title":"a section of the journal Frontiers in Microbiology Comparative Analysis of Salivary Gland Proteomes of Two Glossina Species that Exhibit Differential Hytrosavirus Pathologies"},{"arc":[[41.0080909729004,29.0522594451904],[-33.9343490600586,18.6259994506836]],"countries":["Turkey","South Africa"],"title":"a section of the journal Frontiers in Microbiology Comparative Analysis of Salivary Gland Proteomes of Two Glossina Species that Exhibit Differential Hytrosavirus Pathologies"},{"arc":[[41.0080909729004,29.0522594451904],[51.9735984802246,5.66384315490723]],"countries":["Turkey","Netherlands"],"title":"a section of the journal Frontiers in Microbiology Comparative Analysis of Salivary Gland Proteomes of Two Glossina Species that Exhibit Differential Hytrosavirus Pathologies"},{"arc":[[37.7697296142578,-122.466094970703],[20.2663593292236,85.8105697631836]],"countries":["United States","India"],"title":"a section of the journal Frontiers in Microbiology Comparative Analysis of Salivary Gland Proteomes of Two Glossina Species that Exhibit Differential Hytrosavirus Pathologies"},{"arc":[[37.7697296142578,-122.466094970703],[-33.9343490600586,18.6259994506836]],"countries":["United States","South Africa"],"title":"a section of the journal Frontiers in Microbiology Comparative Analysis of Salivary Gland Proteomes of Two Glossina Species that Exhibit Differential Hytrosavirus Pathologies"},{"arc":[[37.7697296142578,-122.466094970703],[51.9735984802246,5.66384315490723]],"countries":["United States","Netherlands"],"title":"a section of the journal Frontiers in Microbiology Comparative Analysis of Salivary Gland Proteomes of Two Glossina Species that Exhibit Differential Hytrosavirus Pathologies"},{"arc":[[20.2663593292236,85.8105697631836],[-33.9343490600586,18.6259994506836]],"countries":["India","South Africa"],"title":"a section of the journal Frontiers in Microbiology Comparative Analysis of Salivary Gland Proteomes of Two Glossina Species that Exhibit Differential Hytrosavirus Pathologies"},{"arc":[[20.2663593292236,85.8105697631836],[51.9735984802246,5.66384315490723]],"countries":["Netherlands","India"],"title":"a section of the journal Frontiers in Microbiology Comparative Analysis of Salivary Gland Proteomes of Two Glossina Species that Exhibit Differential Hytrosavirus Pathologies"},{"arc":[[-33.9343490600586,18.6259994506836],[51.9735984802246,5.66384315490723]],"countries":["Netherlands","South Africa"],"title":"a section of the journal Frontiers in Microbiology Comparative Analysis of Salivary Gland Proteomes of Two Glossina Species that Exhibit Differential Hytrosavirus Pathologies"},{"arc":[[36.6518402099609,117.120086669922],[36.4687042236328,118.517120361328]],"countries":["China"],"title":"Clinical Study Viral Aetiology in Adults with Acute Upper Respiratory Tract Infection in Jinan, Northern China"},{"arc":[[36.6518402099609,117.120086669922],[30.5363693237305,114.365432739258]],"countries":["China"],"title":"Clinical Study Viral Aetiology in Adults with Acute Upper Respiratory Tract Infection in Jinan, Northern China"},{"arc":[[36.4687042236328,118.517120361328],[30.5363693237305,114.365432739258]],"countries":["China"],"title":"Clinical Study Viral Aetiology in Adults with Acute Upper Respiratory Tract Infection in Jinan, Northern China"},{"arc":[[53.4858894348145,-2.94901990890503],[51.4948616027832,-0.178790003061295]],"countries":["United Kingdom"],"title":"European Journal of Case Reports in Internal Medicine An Uncommon Cause of Spontaneous Pneumomediastinum and Subcutaneous Emphysema"},{"arc":[[49.0121917724609,0.703100025653839],[40.9437103271484,40.2619209289551]],"countries":["Turkey","France"],"title":"EPIDEMIOLOGIC INVESTIGATION Epidemiological investigation of the 119th confirmed Middle East Respiratory Syndrome coronavirus case with an indefinite mode of transmission during the Pyeongtaek outbreak in Korea"},{"arc":[[49.0121917724609,0.703100025653839],[14.477560043335,120.89826965332]],"countries":["France","Philippines"],"title":"EPIDEMIOLOGIC INVESTIGATION Epidemiological investigation of the 119th confirmed Middle East Respiratory Syndrome coronavirus case with an indefinite mode of transmission during the Pyeongtaek outbreak in Korea"},{"arc":[[40.9437103271484,40.2619209289551],[14.477560043335,120.89826965332]],"countries":["Turkey","Philippines"],"title":"EPIDEMIOLOGIC INVESTIGATION Epidemiological investigation of the 119th confirmed Middle East Respiratory Syndrome coronavirus case with an indefinite mode of transmission during the Pyeongtaek outbreak in Korea"},{"arc":[[40.9437103271484,40.2619209289551],[40.9437103271484,40.2619209289551]],"countries":["Turkey"],"title":"EPIDEMIOLOGIC INVESTIGATION Epidemiological investigation of the 119th confirmed Middle East Respiratory Syndrome coronavirus case with an indefinite mode of transmission during the Pyeongtaek outbreak in Korea"},{"arc":[[14.477560043335,120.89826965332],[40.9437103271484,40.2619209289551]],"countries":["Turkey","Philippines"],"title":"EPIDEMIOLOGIC INVESTIGATION Epidemiological investigation of the 119th confirmed Middle East Respiratory Syndrome coronavirus case with an indefinite mode of transmission during the Pyeongtaek outbreak in Korea"},{"arc":[[40.8510894775391,-73.8444290161133],[40.9437103271484,40.2619209289551]],"countries":["Turkey","United States"],"title":"Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible 1 to Tibrovirus Particle Cell Entry 2 3 Running Title: 3/5 words"},{"arc":[[40.8510894775391,-73.8444290161133],[39.0048141479492,-77.0975341796875]],"countries":["United States"],"title":"Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible 1 to Tibrovirus Particle Cell Entry 2 3 Running Title: 3/5 words"},{"arc":[[40.8510894775391,-73.8444290161133],[42.8098297119141,-88.3805541992188]],"countries":["United States"],"title":"Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible 1 to Tibrovirus Particle Cell Entry 2 3 Running Title: 3/5 words"},{"arc":[[40.8510894775391,-73.8444290161133],[37.8056831359863,-122.268104553223]],"countries":["United States"],"title":"Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible 1 to Tibrovirus Particle Cell Entry 2 3 Running Title: 3/5 words"},{"arc":[[40.8510894775391,-73.8444290161133],[30.2787208557129,-97.7324523925781]],"countries":["United States"],"title":"Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible 1 to Tibrovirus Particle Cell Entry 2 3 Running Title: 3/5 words"},{"arc":[[40.8510894775391,-73.8444290161133],[43.0670013427734,-89.4000015258789]],"countries":["United States"],"title":"Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible 1 to Tibrovirus Particle Cell Entry 2 3 Running Title: 3/5 words"},{"arc":[[40.9437103271484,40.2619209289551],[40.9437103271484,40.2619209289551]],"countries":["Turkey"],"title":"Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible 1 to Tibrovirus Particle Cell Entry 2 3 Running Title: 3/5 words"},{"arc":[[40.9437103271484,40.2619209289551],[39.0048141479492,-77.0975341796875]],"countries":["Turkey","United States"],"title":"Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible 1 to Tibrovirus Particle Cell Entry 2 3 Running Title: 3/5 words"},{"arc":[[40.9437103271484,40.2619209289551],[42.8098297119141,-88.3805541992188]],"countries":["Turkey","United States"],"title":"Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible 1 to Tibrovirus Particle Cell Entry 2 3 Running Title: 3/5 words"},{"arc":[[40.9437103271484,40.2619209289551],[37.8056831359863,-122.268104553223]],"countries":["Turkey","United States"],"title":"Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible 1 to Tibrovirus Particle Cell Entry 2 3 Running Title: 3/5 words"},{"arc":[[40.9437103271484,40.2619209289551],[30.2787208557129,-97.7324523925781]],"countries":["Turkey","United States"],"title":"Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible 1 to Tibrovirus Particle Cell Entry 2 3 Running Title: 3/5 words"},{"arc":[[40.9437103271484,40.2619209289551],[43.0670013427734,-89.4000015258789]],"countries":["Turkey","United States"],"title":"Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible 1 to Tibrovirus Particle Cell Entry 2 3 Running Title: 3/5 words"},{"arc":[[39.0048141479492,-77.0975341796875],[42.8098297119141,-88.3805541992188]],"countries":["United States"],"title":"Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible 1 to Tibrovirus Particle Cell Entry 2 3 Running Title: 3/5 words"},{"arc":[[39.0048141479492,-77.0975341796875],[37.8056831359863,-122.268104553223]],"countries":["United States"],"title":"Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible 1 to Tibrovirus Particle Cell Entry 2 3 Running Title: 3/5 words"},{"arc":[[39.0048141479492,-77.0975341796875],[30.2787208557129,-97.7324523925781]],"countries":["United States"],"title":"Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible 1 to Tibrovirus Particle Cell Entry 2 3 Running Title: 3/5 words"},{"arc":[[39.0048141479492,-77.0975341796875],[43.0670013427734,-89.4000015258789]],"countries":["United States"],"title":"Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible 1 to Tibrovirus Particle Cell Entry 2 3 Running Title: 3/5 words"},{"arc":[[42.8098297119141,-88.3805541992188],[37.8056831359863,-122.268104553223]],"countries":["United States"],"title":"Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible 1 to Tibrovirus Particle Cell Entry 2 3 Running Title: 3/5 words"},{"arc":[[42.8098297119141,-88.3805541992188],[30.2787208557129,-97.7324523925781]],"countries":["United States"],"title":"Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible 1 to Tibrovirus Particle Cell Entry 2 3 Running Title: 3/5 words"},{"arc":[[42.8098297119141,-88.3805541992188],[43.0670013427734,-89.4000015258789]],"countries":["United States"],"title":"Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible 1 to Tibrovirus Particle Cell Entry 2 3 Running Title: 3/5 words"},{"arc":[[37.8056831359863,-122.268104553223],[30.2787208557129,-97.7324523925781]],"countries":["United States"],"title":"Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible 1 to Tibrovirus Particle Cell Entry 2 3 Running Title: 3/5 words"},{"arc":[[37.8056831359863,-122.268104553223],[43.0670013427734,-89.4000015258789]],"countries":["United States"],"title":"Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible 1 to Tibrovirus Particle Cell Entry 2 3 Running Title: 3/5 words"},{"arc":[[30.2787208557129,-97.7324523925781],[43.0670013427734,-89.4000015258789]],"countries":["United States"],"title":"Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible 1 to Tibrovirus Particle Cell Entry 2 3 Running Title: 3/5 words"},{"arc":[[40.7840995788574,-84.1892776489258],[42.3354797363281,-71.1043930053711]],"countries":["United States"],"title":"Journal of Translational Medicine Transfusion-transmitted infections"},{"arc":[[40.7840995788574,-84.1892776489258],[30.5934391021729,31.2882404327393]],"countries":["United States","Egypt"],"title":"Journal of Translational Medicine Transfusion-transmitted infections"},{"arc":[[42.3354797363281,-71.1043930053711],[30.5934391021729,31.2882404327393]],"countries":["United States","Egypt"],"title":"Journal of Translational Medicine Transfusion-transmitted infections"},{"arc":[[31.823558807373,117.231567382812],[1.29718005657196,103.77774810791]],"countries":["China","Singapore"],"title":"Solution conformations of Zika NS2B-NS3pro and its inhibition by natural products from edible plants"},{"arc":[[41.7091674804688,-87.9819946289062],[33.9756317138672,-117.331169128418]],"countries":["United States"],"title":"Crystal structure of Nsp15 endoribonuclease NendoU from SARS-CoV-2 Running Title: Structure of Nsp15 from SARS-CoV-2"},{"arc":[[41.7091674804688,-87.9819946289062],[41.7922172546387,-87.6018371582031]],"countries":["United States"],"title":"Crystal structure of Nsp15 endoribonuclease NendoU from SARS-CoV-2 Running Title: Structure of Nsp15 from SARS-CoV-2"},{"arc":[[33.9756317138672,-117.331169128418],[41.7922172546387,-87.6018371582031]],"countries":["United States"],"title":"Crystal structure of Nsp15 endoribonuclease NendoU from SARS-CoV-2 Running Title: Structure of Nsp15 from SARS-CoV-2"},{"arc":[[25.2651195526123,82.9921417236328],[40.7182693481445,46.4133987426758]],"countries":["India","Azerbaijan"],"title":"Elevated transmission of upper respiratory illness among new recruits in military barracks in Thailand"},{"arc":[[40.9437103271484,40.2619209289551],[40.8081588745117,-73.9636535644531]],"countries":["Turkey","United States"],"title":"Identifying Hosts of Families of Viruses: A Machine Learning Approach"},{"arc":[[18.5423393249512,73.828727722168],[36.5631141662598,103.735809326172]],"countries":["China","India"],"title":"The Rescue and Characterization of Recombinant, Microcephaly-Associated Zika Viruses as Single-Round Infectious Particles"},{"arc":[[18.5423393249512,73.828727722168],[9.36855030059814,-83.6394882202148]],"countries":["India","Costa Rica"],"title":"The Rescue and Characterization of Recombinant, Microcephaly-Associated Zika Viruses as Single-Round Infectious Particles"},{"arc":[[36.5631141662598,103.735809326172],[9.36855030059814,-83.6394882202148]],"countries":["China","Costa Rica"],"title":"The Rescue and Characterization of Recombinant, Microcephaly-Associated Zika Viruses as Single-Round Infectious Particles"},{"arc":[[52.7308082580566,-122.448257446289],[-37.797981262207,144.959045410156]],"countries":["Canada","Australia"],"title":"Improving immunological insights into the ferret model of human viral infectious disease"},{"arc":[[-35.2775688171387,149.12646484375],[32.9052963256836,-117.243560791016]],"countries":["Australia","United States"],"title":"Ministry of Health, Jakarta, Indonesia, 2 National Health Institute Research and Development, Ministry of Health"},{"arc":[[44.773998260498,-117.829887390137],[42.4463500976562,-76.4826889038086]],"countries":["United States"],"title":"Expression of 9-O-and 7,9-O-acetyl modified sialic acid in cells and their effects 5 on influenza viruses 6 7"},{"arc":[[43.0435333251953,-2.61686491966248],[51.1218070983887,10.4006948471069]],"countries":["Spain","Germany"],"title":"Detection of alpha and betacoronaviruses in multiple Iberian bat species"},{"arc":[[51.1218070983887,10.4006948471069],[51.1218070983887,10.4006948471069]],"countries":["Germany"],"title":"Detection of alpha and betacoronaviruses in multiple Iberian bat species"},{"arc":[[29.7107791900635,-95.3966522216797],[42.3374290466309,-71.1058197021484]],"countries":["United States"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[29.7107791900635,-95.3966522216797],[39.75265,30.48148]],"countries":["United States","Turkey"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[29.7107791900635,-95.3966522216797],[51.4269409179688,-0.174720004200935]],"countries":["United States","United Kingdom"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[29.7107791900635,-95.3966522216797],[32.8808288574219,-84.6852798461914]],"countries":["United States"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[29.7107791900635,-95.3966522216797],[47.3191909790039,5.06463003158569]],"countries":["United States","France"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[29.7107791900635,-95.3966522216797],[51.1638,4.40115]],"countries":["United States","Belgium"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[29.7107791900635,-95.3966522216797],[-26.193000793457,28.18630027771]],"countries":["United States","South Africa"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[42.3374290466309,-71.1058197021484],[39.75265,30.48148]],"countries":["United States","Turkey"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[42.3374290466309,-71.1058197021484],[51.4269409179688,-0.174720004200935]],"countries":["United States","United Kingdom"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[42.3374290466309,-71.1058197021484],[32.8808288574219,-84.6852798461914]],"countries":["United States"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[42.3374290466309,-71.1058197021484],[47.3191909790039,5.06463003158569]],"countries":["United States","France"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[42.3374290466309,-71.1058197021484],[51.1638,4.40115]],"countries":["United States","Belgium"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[42.3374290466309,-71.1058197021484],[-26.193000793457,28.18630027771]],"countries":["United States","South Africa"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[39.75265,30.48148],[51.4269409179688,-0.174720004200935]],"countries":["Turkey","United Kingdom"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[39.75265,30.48148],[32.8808288574219,-84.6852798461914]],"countries":["United States","Turkey"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[39.75265,30.48148],[47.3191909790039,5.06463003158569]],"countries":["Turkey","France"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[39.75265,30.48148],[51.1638,4.40115]],"countries":["Turkey","Belgium"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[39.75265,30.48148],[-26.193000793457,28.18630027771]],"countries":["Turkey","South Africa"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[51.4269409179688,-0.174720004200935],[32.8808288574219,-84.6852798461914]],"countries":["United States","United Kingdom"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[51.4269409179688,-0.174720004200935],[47.3191909790039,5.06463003158569]],"countries":["United Kingdom","France"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[51.4269409179688,-0.174720004200935],[51.1638,4.40115]],"countries":["United Kingdom","Belgium"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[51.4269409179688,-0.174720004200935],[-26.193000793457,28.18630027771]],"countries":["United Kingdom","South Africa"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[32.8808288574219,-84.6852798461914],[47.3191909790039,5.06463003158569]],"countries":["United States","France"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[32.8808288574219,-84.6852798461914],[51.1638,4.40115]],"countries":["United States","Belgium"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[32.8808288574219,-84.6852798461914],[-26.193000793457,28.18630027771]],"countries":["United States","South Africa"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[47.3191909790039,5.06463003158569],[51.1638,4.40115]],"countries":["France","Belgium"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[47.3191909790039,5.06463003158569],[-26.193000793457,28.18630027771]],"countries":["France","South Africa"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[51.1638,4.40115],[-26.193000793457,28.18630027771]],"countries":["Belgium","South Africa"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[40.1861572265625,116.418983459473],[43.9928398132324,0.229560002684593]],"countries":["France","China"],"title":"Association of Mannose-binding Lectin Polymorphisms with Tuberculosis Susceptibility among Chinese OPEN"},{"arc":[[40.1861572265625,116.418983459473],[38.0427589416504,114.514297485352]],"countries":["China"],"title":"Association of Mannose-binding Lectin Polymorphisms with Tuberculosis Susceptibility among Chinese OPEN"},{"arc":[[40.1861572265625,116.418983459473],[37.7697296142578,-122.466094970703]],"countries":["United States","China"],"title":"Association of Mannose-binding Lectin Polymorphisms with Tuberculosis Susceptibility among Chinese OPEN"},{"arc":[[43.9928398132324,0.229560002684593],[38.0427589416504,114.514297485352]],"countries":["France","China"],"title":"Association of Mannose-binding Lectin Polymorphisms with Tuberculosis Susceptibility among Chinese OPEN"},{"arc":[[43.9928398132324,0.229560002684593],[37.7697296142578,-122.466094970703]],"countries":["United States","France"],"title":"Association of Mannose-binding Lectin Polymorphisms with Tuberculosis Susceptibility among Chinese OPEN"},{"arc":[[38.0427589416504,114.514297485352],[37.7697296142578,-122.466094970703]],"countries":["United States","China"],"title":"Association of Mannose-binding Lectin Polymorphisms with Tuberculosis Susceptibility among Chinese OPEN"},{"arc":[[40.1861572265625,116.418983459473],[30.3002605438232,108.037666320801]],"countries":["China"],"title":"Incidence and Outcomes of Acute Respiratory Distress Syndrome A Nationwide Registry-Based Study in Taiwan, 1997 to 2011"},{"arc":[[39.9925537109375,116.310485839844],[27.3303279876709,128.57194519043]],"countries":["China","Japan"],"title":"Burden of respiratory syncytial virus infections in China: Systematic review and meta-analysis"},{"arc":[[39.9925537109375,116.310485839844],[42.2077713012695,-78.1342010498047]],"countries":["China","United States"],"title":"Burden of respiratory syncytial virus infections in China: Systematic review and meta-analysis"},{"arc":[[39.9925537109375,116.310485839844],[-31.61016,-60.69643]],"countries":["China","Argentina"],"title":"Burden of respiratory syncytial virus infections in China: Systematic review and meta-analysis"},{"arc":[[27.3303279876709,128.57194519043],[42.2077713012695,-78.1342010498047]],"countries":["Japan","United States"],"title":"Burden of respiratory syncytial virus infections in China: Systematic review and meta-analysis"},{"arc":[[27.3303279876709,128.57194519043],[-31.61016,-60.69643]],"countries":["Japan","Argentina"],"title":"Burden of respiratory syncytial virus infections in China: Systematic review and meta-analysis"},{"arc":[[42.2077713012695,-78.1342010498047],[-31.61016,-60.69643]],"countries":["United States","Argentina"],"title":"Burden of respiratory syncytial virus infections in China: Systematic review and meta-analysis"},{"arc":[[52.5014038085938,13.4023313522339],[46.8767318725586,7.36887979507446]],"countries":["Germany","Switzerland"],"title":"The papain-like protease determines a virulence trait that varies among members of the SARS-coronavirus species"},{"arc":[[52.5014038085938,13.4023313522339],[41.9982795715332,-87.6571731567383]],"countries":["Germany","United States"],"title":"The papain-like protease determines a virulence trait that varies among members of the SARS-coronavirus species"},{"arc":[[52.5014038085938,13.4023313522339],[40.9437103271484,40.2619209289551]],"countries":["Turkey","Germany"],"title":"The papain-like protease determines a virulence trait that varies among members of the SARS-coronavirus species"},{"arc":[[52.5014038085938,13.4023313522339],[50.7338905334473,7.10222196578979]],"countries":["Germany"],"title":"The papain-like protease determines a virulence trait that varies among members of the SARS-coronavirus species"},{"arc":[[46.8767318725586,7.36887979507446],[41.9982795715332,-87.6571731567383]],"countries":["Switzerland","United States"],"title":"The papain-like protease determines a virulence trait that varies among members of the SARS-coronavirus species"},{"arc":[[46.8767318725586,7.36887979507446],[40.9437103271484,40.2619209289551]],"countries":["Turkey","Switzerland"],"title":"The papain-like protease determines a virulence trait that varies among members of the SARS-coronavirus species"},{"arc":[[46.8767318725586,7.36887979507446],[50.7338905334473,7.10222196578979]],"countries":["Switzerland","Germany"],"title":"The papain-like protease determines a virulence trait that varies among members of the SARS-coronavirus species"},{"arc":[[41.9982795715332,-87.6571731567383],[41.9982795715332,-87.6571731567383]],"countries":["United States"],"title":"The papain-like protease determines a virulence trait that varies among members of the SARS-coronavirus species"},{"arc":[[41.9982795715332,-87.6571731567383],[40.9437103271484,40.2619209289551]],"countries":["Turkey","United States"],"title":"The papain-like protease determines a virulence trait that varies among members of the SARS-coronavirus species"},{"arc":[[41.9982795715332,-87.6571731567383],[50.7338905334473,7.10222196578979]],"countries":["United States","Germany"],"title":"The papain-like protease determines a virulence trait that varies among members of the SARS-coronavirus species"},{"arc":[[40.9437103271484,40.2619209289551],[50.7338905334473,7.10222196578979]],"countries":["Turkey","Germany"],"title":"The papain-like protease determines a virulence trait that varies among members of the SARS-coronavirus species"},{"arc":[[50.7338905334473,7.10222196578979],[50.7338905334473,7.10222196578979]],"countries":["Germany"],"title":"The papain-like protease determines a virulence trait that varies among members of the SARS-coronavirus species"},{"arc":[[44.9948196411133,-93.41455078125],[50.7338905334473,7.10222196578979]],"countries":["United States","Germany"],"title":"Virology Journal Identification of a contemporary human parechovirus type 1 by VIDISCA and characterisation of its full genome"},{"arc":[[43.2412185668945,-2.8500440120697],[51.1218070983887,10.4006948471069]],"countries":["Spain","Germany"],"title":"Enterovirus D68-associated respiratory and neurological illness in Spain, 2014-2018"},{"arc":[[43.2412185668945,-2.8500440120697],[-16.499080657959,-68.1337814331055]],"countries":["Spain","Bolivia"],"title":"Enterovirus D68-associated respiratory and neurological illness in Spain, 2014-2018"},{"arc":[[43.2412185668945,-2.8500440120697],[41.6720504760742,2.2520899772644]],"countries":["Spain"],"title":"Enterovirus D68-associated respiratory and neurological illness in Spain, 2014-2018"},{"arc":[[43.2412185668945,-2.8500440120697],[48.5444183349609,12.1591682434082]],"countries":["Spain","Germany"],"title":"Enterovirus D68-associated respiratory and neurological illness in Spain, 2014-2018"},{"arc":[[43.2412185668945,-2.8500440120697],[28.0604705810547,-15.4747295379639]],"countries":["Spain"],"title":"Enterovirus D68-associated respiratory and neurological illness in Spain, 2014-2018"},{"arc":[[51.1218070983887,10.4006948471069],[-16.499080657959,-68.1337814331055]],"countries":["Germany","Bolivia"],"title":"Enterovirus D68-associated respiratory and neurological illness in Spain, 2014-2018"},{"arc":[[51.1218070983887,10.4006948471069],[41.6720504760742,2.2520899772644]],"countries":["Germany","Spain"],"title":"Enterovirus D68-associated respiratory and neurological illness in Spain, 2014-2018"},{"arc":[[51.1218070983887,10.4006948471069],[48.5444183349609,12.1591682434082]],"countries":["Germany"],"title":"Enterovirus D68-associated respiratory and neurological illness in Spain, 2014-2018"},{"arc":[[51.1218070983887,10.4006948471069],[51.1218070983887,10.4006948471069]],"countries":["Germany"],"title":"Enterovirus D68-associated respiratory and neurological illness in Spain, 2014-2018"},{"arc":[[51.1218070983887,10.4006948471069],[28.0604705810547,-15.4747295379639]],"countries":["Germany","Spain"],"title":"Enterovirus D68-associated respiratory and neurological illness in Spain, 2014-2018"},{"arc":[[-16.499080657959,-68.1337814331055],[41.6720504760742,2.2520899772644]],"countries":["Bolivia","Spain"],"title":"Enterovirus D68-associated respiratory and neurological illness in Spain, 2014-2018"},{"arc":[[-16.499080657959,-68.1337814331055],[48.5444183349609,12.1591682434082]],"countries":["Germany","Bolivia"],"title":"Enterovirus D68-associated respiratory and neurological illness in Spain, 2014-2018"},{"arc":[[-16.499080657959,-68.1337814331055],[51.1218070983887,10.4006948471069]],"countries":["Germany","Bolivia"],"title":"Enterovirus D68-associated respiratory and neurological illness in Spain, 2014-2018"},{"arc":[[-16.499080657959,-68.1337814331055],[28.0604705810547,-15.4747295379639]],"countries":["Bolivia","Spain"],"title":"Enterovirus D68-associated respiratory and neurological illness in Spain, 2014-2018"},{"arc":[[41.6720504760742,2.2520899772644],[48.5444183349609,12.1591682434082]],"countries":["Germany","Spain"],"title":"Enterovirus D68-associated respiratory and neurological illness in Spain, 2014-2018"},{"arc":[[41.6720504760742,2.2520899772644],[51.1218070983887,10.4006948471069]],"countries":["Germany","Spain"],"title":"Enterovirus D68-associated respiratory and neurological illness in Spain, 2014-2018"},{"arc":[[41.6720504760742,2.2520899772644],[28.0604705810547,-15.4747295379639]],"countries":["Spain"],"title":"Enterovirus D68-associated respiratory and neurological illness in Spain, 2014-2018"},{"arc":[[48.5444183349609,12.1591682434082],[51.1218070983887,10.4006948471069]],"countries":["Germany"],"title":"Enterovirus D68-associated respiratory and neurological illness in Spain, 2014-2018"},{"arc":[[48.5444183349609,12.1591682434082],[28.0604705810547,-15.4747295379639]],"countries":["Germany","Spain"],"title":"Enterovirus D68-associated respiratory and neurological illness in Spain, 2014-2018"},{"arc":[[-85.0169982910156,-167.5],[40.9437103271484,40.2619209289551]],"countries":["Turkey","NOCOUNTRY"],"title":"Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing"},{"arc":[[-85.0169982910156,-167.5],[55.7387313842773,12.5470895767212]],"countries":["NOCOUNTRY","Denmark"],"title":"Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing"},{"arc":[[-85.0169982910156,-167.5],[45.8021583557129,126.535797119141]],"countries":["NOCOUNTRY","China"],"title":"Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing"},{"arc":[[-85.0169982910156,-167.5],[40.7182693481445,46.4133987426758]],"countries":["Azerbaijan","NOCOUNTRY"],"title":"Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing"},{"arc":[[-85.0169982910156,-167.5],[55.6756706237793,12.5675601959229]],"countries":["NOCOUNTRY","Denmark"],"title":"Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing"},{"arc":[[40.9437103271484,40.2619209289551],[55.7387313842773,12.5470895767212]],"countries":["Turkey","Denmark"],"title":"Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing"},{"arc":[[40.9437103271484,40.2619209289551],[45.8021583557129,126.535797119141]],"countries":["Turkey","China"],"title":"Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing"},{"arc":[[40.9437103271484,40.2619209289551],[40.7182693481445,46.4133987426758]],"countries":["Turkey","Azerbaijan"],"title":"Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing"},{"arc":[[40.9437103271484,40.2619209289551],[55.6756706237793,12.5675601959229]],"countries":["Turkey","Denmark"],"title":"Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing"},{"arc":[[55.7387313842773,12.5470895767212],[45.8021583557129,126.535797119141]],"countries":["Denmark","China"],"title":"Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing"},{"arc":[[55.7387313842773,12.5470895767212],[40.7182693481445,46.4133987426758]],"countries":["Azerbaijan","Denmark"],"title":"Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing"},{"arc":[[55.7387313842773,12.5470895767212],[55.6756706237793,12.5675601959229]],"countries":["Denmark"],"title":"Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing"},{"arc":[[45.8021583557129,126.535797119141],[40.7182693481445,46.4133987426758]],"countries":["Azerbaijan","China"],"title":"Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing"},{"arc":[[45.8021583557129,126.535797119141],[55.6756706237793,12.5675601959229]],"countries":["Denmark","China"],"title":"Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing"},{"arc":[[40.7182693481445,46.4133987426758],[55.6756706237793,12.5675601959229]],"countries":["Azerbaijan","Denmark"],"title":"Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing"},{"arc":[[42.3502082824707,-71.0988693237305],[-33.88618,151.18716]],"countries":["United States","Australia"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[42.3502082824707,-71.0988693237305],[54.5704803466797,-1.23447000980377]],"countries":["United States","United Kingdom"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[42.3502082824707,-71.0988693237305],[-23.5594444274902,-46.7238883972168]],"countries":["United States","NOCOUNTRY"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[42.3502082824707,-71.0988693237305],[51.9630088806152,7.61780977249146]],"countries":["United States","Germany"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[42.3502082824707,-71.0988693237305],[28.6008148193359,-81.1996078491211]],"countries":["United States"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[42.3502082824707,-71.0988693237305],[35.1019592285156,-106.591567993164]],"countries":["United States"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[42.3502082824707,-71.0988693237305],[53.3718719482422,-3.0949079990387]],"countries":["United States","United Kingdom"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[-33.88618,151.18716],[54.5704803466797,-1.23447000980377]],"countries":["Australia","United Kingdom"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[-33.88618,151.18716],[-23.5594444274902,-46.7238883972168]],"countries":["NOCOUNTRY","Australia"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[-33.88618,151.18716],[51.9630088806152,7.61780977249146]],"countries":["Australia","Germany"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[-33.88618,151.18716],[28.6008148193359,-81.1996078491211]],"countries":["Australia","United States"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[-33.88618,151.18716],[35.1019592285156,-106.591567993164]],"countries":["Australia","United States"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[-33.88618,151.18716],[53.3718719482422,-3.0949079990387]],"countries":["Australia","United Kingdom"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[54.5704803466797,-1.23447000980377],[-23.5594444274902,-46.7238883972168]],"countries":["NOCOUNTRY","United Kingdom"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[54.5704803466797,-1.23447000980377],[51.9630088806152,7.61780977249146]],"countries":["United Kingdom","Germany"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[54.5704803466797,-1.23447000980377],[28.6008148193359,-81.1996078491211]],"countries":["United Kingdom","United States"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[54.5704803466797,-1.23447000980377],[35.1019592285156,-106.591567993164]],"countries":["United Kingdom","United States"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[54.5704803466797,-1.23447000980377],[53.3718719482422,-3.0949079990387]],"countries":["United Kingdom"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[-23.5594444274902,-46.7238883972168],[51.9630088806152,7.61780977249146]],"countries":["NOCOUNTRY","Germany"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[-23.5594444274902,-46.7238883972168],[28.6008148193359,-81.1996078491211]],"countries":["NOCOUNTRY","United States"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[-23.5594444274902,-46.7238883972168],[35.1019592285156,-106.591567993164]],"countries":["NOCOUNTRY","United States"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[-23.5594444274902,-46.7238883972168],[53.3718719482422,-3.0949079990387]],"countries":["NOCOUNTRY","United Kingdom"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[51.9630088806152,7.61780977249146],[28.6008148193359,-81.1996078491211]],"countries":["Germany","United States"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[51.9630088806152,7.61780977249146],[35.1019592285156,-106.591567993164]],"countries":["Germany","United States"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[51.9630088806152,7.61780977249146],[53.3718719482422,-3.0949079990387]],"countries":["Germany","United Kingdom"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[28.6008148193359,-81.1996078491211],[35.1019592285156,-106.591567993164]],"countries":["United States"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[28.6008148193359,-81.1996078491211],[53.3718719482422,-3.0949079990387]],"countries":["United States","United Kingdom"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[35.1019592285156,-106.591567993164],[53.3718719482422,-3.0949079990387]],"countries":["United States","United Kingdom"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[51.457706451416,-2.59726095199585],[51.5002288818359,-0.178939998149872]],"countries":["United Kingdom"],"title":"Management of Kawasaki disease"},{"arc":[[51.457706451416,-2.59726095199585],[53.330680847168,-3.02163004875183]],"countries":["United Kingdom"],"title":"Management of Kawasaki disease"},{"arc":[[51.5002288818359,-0.178939998149872],[53.330680847168,-3.02163004875183]],"countries":["United Kingdom"],"title":"Management of Kawasaki disease"},{"arc":[[40.9437103271484,40.2619209289551],[23.7489929199219,120.971282958984]],"countries":["Turkey","Taiwan"],"title":"BMC Public Health The immediate effects of the severe acute respiratory syndrome (SARS) epidemic on childbirth in Taiwan"},{"arc":[[40.9437103271484,40.2619209289551],[33.2227516174316,107.54564666748]],"countries":["Turkey","China"],"title":"BMC Public Health The immediate effects of the severe acute respiratory syndrome (SARS) epidemic on childbirth in Taiwan"},{"arc":[[23.7489929199219,120.971282958984],[33.2227516174316,107.54564666748]],"countries":["Taiwan","China"],"title":"BMC Public Health The immediate effects of the severe acute respiratory syndrome (SARS) epidemic on childbirth in Taiwan"},{"arc":[[47.3280982971191,-114.292999267578],[-25.1099891662598,30.7521800994873]],"countries":["United States","South Africa"],"title":"Access to"},{"arc":[[47.3280982971191,-114.292999267578],[40.7182693481445,46.4133987426758]],"countries":["United States","Azerbaijan"],"title":"Access to"},{"arc":[[47.3280982971191,-114.292999267578],[-31.61016,-60.69643]],"countries":["United States","Argentina"],"title":"Access to"},{"arc":[[47.3280982971191,-114.292999267578],[55.8721008300781,-4.28659009933472]],"countries":["United States","United Kingdom"],"title":"Access to"},{"arc":[[47.3280982971191,-114.292999267578],[-25.7523803710938,28.2516193389893]],"countries":["United States","South Africa"],"title":"Access to"},{"arc":[[47.3280982971191,-114.292999267578],[41.87774,12.49506]],"countries":["United States","Italy"],"title":"Access to"},{"arc":[[-25.1099891662598,30.7521800994873],[40.7182693481445,46.4133987426758]],"countries":["Azerbaijan","South Africa"],"title":"Access to"},{"arc":[[-25.1099891662598,30.7521800994873],[-31.61016,-60.69643]],"countries":["South Africa","Argentina"],"title":"Access to"},{"arc":[[-25.1099891662598,30.7521800994873],[55.8721008300781,-4.28659009933472]],"countries":["South Africa","United Kingdom"],"title":"Access to"},{"arc":[[-25.1099891662598,30.7521800994873],[-25.7523803710938,28.2516193389893]],"countries":["South Africa"],"title":"Access to"},{"arc":[[-25.1099891662598,30.7521800994873],[41.87774,12.49506]],"countries":["South Africa","Italy"],"title":"Access to"},{"arc":[[40.7182693481445,46.4133987426758],[-31.61016,-60.69643]],"countries":["Azerbaijan","Argentina"],"title":"Access to"},{"arc":[[40.7182693481445,46.4133987426758],[55.8721008300781,-4.28659009933472]],"countries":["Azerbaijan","United Kingdom"],"title":"Access to"},{"arc":[[40.7182693481445,46.4133987426758],[-25.7523803710938,28.2516193389893]],"countries":["Azerbaijan","South Africa"],"title":"Access to"},{"arc":[[40.7182693481445,46.4133987426758],[41.87774,12.49506]],"countries":["Azerbaijan","Italy"],"title":"Access to"},{"arc":[[-31.61016,-60.69643],[55.8721008300781,-4.28659009933472]],"countries":["United Kingdom","Argentina"],"title":"Access to"},{"arc":[[-31.61016,-60.69643],[-25.7523803710938,28.2516193389893]],"countries":["Argentina","South Africa"],"title":"Access to"},{"arc":[[-31.61016,-60.69643],[41.87774,12.49506]],"countries":["Argentina","Italy"],"title":"Access to"},{"arc":[[55.8721008300781,-4.28659009933472],[-25.7523803710938,28.2516193389893]],"countries":["United Kingdom","South Africa"],"title":"Access to"},{"arc":[[55.8721008300781,-4.28659009933472],[41.87774,12.49506]],"countries":["United Kingdom","Italy"],"title":"Access to"},{"arc":[[-25.7523803710938,28.2516193389893],[41.87774,12.49506]],"countries":["South Africa","Italy"],"title":"Access to"},{"arc":[[41.7278709411621,44.764778137207],[39.9046897888184,116.407173156738]],"countries":["Georgia","China"],"title":"Gender differences in patients with COVID-19: Focus on severity and mortality"},{"arc":[[41.7278709411621,44.764778137207],[31.0254402160645,121.436302185059]],"countries":["Georgia","China"],"title":"Gender differences in patients with COVID-19: Focus on severity and mortality"},{"arc":[[41.7278709411621,44.764778137207],[30.5363693237305,114.365432739258]],"countries":["Georgia","China"],"title":"Gender differences in patients with COVID-19: Focus on severity and mortality"},{"arc":[[39.9046897888184,116.407173156738],[31.0254402160645,121.436302185059]],"countries":["China"],"title":"Gender differences in patients with COVID-19: Focus on severity and mortality"},{"arc":[[39.9046897888184,116.407173156738],[30.5363693237305,114.365432739258]],"countries":["China"],"title":"Gender differences in patients with COVID-19: Focus on severity and mortality"},{"arc":[[31.0254402160645,121.436302185059],[30.5363693237305,114.365432739258]],"countries":["China"],"title":"Gender differences in patients with COVID-19: Focus on severity and mortality"},{"arc":[[41.7278709411621,44.764778137207],[-19.9233207702637,-43.9290504455566]],"countries":["Georgia","Brazil"],"title":") A Multiplex Asymmetric Reverse Transcription-PCR Assay Combined With an Electrochemical DNA Sensor for Simultaneously Detecting and Subtyping Influenza A Multiplex Asymmetric Reverse Transcription-PCR Assay Combined With an Electrochemical DNA Sensor for Simultaneously Detecting and Subtyping Influenza A Viruses"},{"arc":[[51.4884300231934,-3.17879009246826],[51.5002288818359,-0.178939998149872]],"countries":["United Kingdom"],"title":"CD200 Receptor Restriction of Myeloid Cell Responses Antagonizes Antiviral Immunity and Facilitates Cytomegalovirus Persistence within Mucosal Tissue"},{"arc":[[51.4884300231934,-3.17879009246826],[55.9452209472656,-3.18803000450134]],"countries":["United Kingdom"],"title":"CD200 Receptor Restriction of Myeloid Cell Responses Antagonizes Antiviral Immunity and Facilitates Cytomegalovirus Persistence within Mucosal Tissue"},{"arc":[[51.4884300231934,-3.17879009246826],[53.4706993103027,-2.23559999465942]],"countries":["United Kingdom"],"title":"CD200 Receptor Restriction of Myeloid Cell Responses Antagonizes Antiviral Immunity and Facilitates Cytomegalovirus Persistence within Mucosal Tissue"},{"arc":[[51.5002288818359,-0.178939998149872],[55.9452209472656,-3.18803000450134]],"countries":["United Kingdom"],"title":"CD200 Receptor Restriction of Myeloid Cell Responses Antagonizes Antiviral Immunity and Facilitates Cytomegalovirus Persistence within Mucosal Tissue"},{"arc":[[51.5002288818359,-0.178939998149872],[53.4706993103027,-2.23559999465942]],"countries":["United Kingdom"],"title":"CD200 Receptor Restriction of Myeloid Cell Responses Antagonizes Antiviral Immunity and Facilitates Cytomegalovirus Persistence within Mucosal Tissue"},{"arc":[[55.9452209472656,-3.18803000450134],[53.4706993103027,-2.23559999465942]],"countries":["United Kingdom"],"title":"CD200 Receptor Restriction of Myeloid Cell Responses Antagonizes Antiviral Immunity and Facilitates Cytomegalovirus Persistence within Mucosal Tissue"},{"arc":[[47.4847412109375,1.68438005447388],[51.2169990539551,4.40000009536743]],"countries":["Belgium","France"],"title":"Metagenomic analysis of a sample from a patient with respiratory tract infection reveals the presence of a -papillomavirus"},{"arc":[[47.4847412109375,1.68438005447388],[52.0896492004395,5.11434984207153]],"countries":["Netherlands","France"],"title":"Metagenomic analysis of a sample from a patient with respiratory tract infection reveals the presence of a -papillomavirus"},{"arc":[[47.4847412109375,1.68438005447388],[52.3687591552734,4.89012002944946]],"countries":["Netherlands","France"],"title":"Metagenomic analysis of a sample from a patient with respiratory tract infection reveals the presence of a -papillomavirus"},{"arc":[[51.2169990539551,4.40000009536743],[52.0896492004395,5.11434984207153]],"countries":["Belgium","Netherlands"],"title":"Metagenomic analysis of a sample from a patient with respiratory tract infection reveals the presence of a -papillomavirus"},{"arc":[[51.2169990539551,4.40000009536743],[52.3687591552734,4.89012002944946]],"countries":["Netherlands","Belgium"],"title":"Metagenomic analysis of a sample from a patient with respiratory tract infection reveals the presence of a -papillomavirus"},{"arc":[[52.0896492004395,5.11434984207153],[52.3687591552734,4.89012002944946]],"countries":["Netherlands"],"title":"Metagenomic analysis of a sample from a patient with respiratory tract infection reveals the presence of a -papillomavirus"},{"arc":[[36.5631141662598,103.735809326172],[41.118278503418,85.1935272216797]],"countries":["China"],"title":"Complex dynamics in an SIS epidemic model induced by nonlinear incidence"},{"arc":[[44.9948196411133,-93.41455078125],[28.8037395477295,79.2010192871094]],"countries":["United States","India"],"title":"Local Evolutionary Patterns of Human Respiratory Syncytial Virus Derived from Whole-Genome Sequencing"},{"arc":[[44.9948196411133,-93.41455078125],[0.537028014659882,37.8567771911621]],"countries":["United States","Kenya"],"title":"Local Evolutionary Patterns of Human Respiratory Syncytial Virus Derived from Whole-Genome Sequencing"},{"arc":[[44.9948196411133,-93.41455078125],[52.598876953125,-1.46688103675842]],"countries":["United States","United Kingdom"],"title":"Local Evolutionary Patterns of Human Respiratory Syncytial Virus Derived from Whole-Genome Sequencing"},{"arc":[[44.9948196411133,-93.41455078125],[39.8202781677246,-105.649436950684]],"countries":["United States"],"title":"Local Evolutionary Patterns of Human Respiratory Syncytial Virus Derived from Whole-Genome Sequencing"},{"arc":[[44.9948196411133,-93.41455078125],[36.708869934082,-119.556427001953]],"countries":["United States"],"title":"Local Evolutionary Patterns of Human Respiratory Syncytial Virus Derived from Whole-Genome Sequencing"},{"arc":[[28.8037395477295,79.2010192871094],[0.537028014659882,37.8567771911621]],"countries":["India","Kenya"],"title":"Local Evolutionary Patterns of Human Respiratory Syncytial Virus Derived from Whole-Genome Sequencing"},{"arc":[[28.8037395477295,79.2010192871094],[52.598876953125,-1.46688103675842]],"countries":["India","United Kingdom"],"title":"Local Evolutionary Patterns of Human Respiratory Syncytial Virus Derived from Whole-Genome Sequencing"},{"arc":[[28.8037395477295,79.2010192871094],[39.8202781677246,-105.649436950684]],"countries":["India","United States"],"title":"Local Evolutionary Patterns of Human Respiratory Syncytial Virus Derived from Whole-Genome Sequencing"},{"arc":[[28.8037395477295,79.2010192871094],[36.708869934082,-119.556427001953]],"countries":["India","United States"],"title":"Local Evolutionary Patterns of Human Respiratory Syncytial Virus Derived from Whole-Genome Sequencing"},{"arc":[[0.537028014659882,37.8567771911621],[52.598876953125,-1.46688103675842]],"countries":["Kenya","United Kingdom"],"title":"Local Evolutionary Patterns of Human Respiratory Syncytial Virus Derived from Whole-Genome Sequencing"},{"arc":[[0.537028014659882,37.8567771911621],[39.8202781677246,-105.649436950684]],"countries":["Kenya","United States"],"title":"Local Evolutionary Patterns of Human Respiratory Syncytial Virus Derived from Whole-Genome Sequencing"},{"arc":[[0.537028014659882,37.8567771911621],[36.708869934082,-119.556427001953]],"countries":["Kenya","United States"],"title":"Local Evolutionary Patterns of Human Respiratory Syncytial Virus Derived from Whole-Genome Sequencing"},{"arc":[[52.598876953125,-1.46688103675842],[39.8202781677246,-105.649436950684]],"countries":["United Kingdom","United States"],"title":"Local Evolutionary Patterns of Human Respiratory Syncytial Virus Derived from Whole-Genome Sequencing"},{"arc":[[52.598876953125,-1.46688103675842],[36.708869934082,-119.556427001953]],"countries":["United Kingdom","United States"],"title":"Local Evolutionary Patterns of Human Respiratory Syncytial Virus Derived from Whole-Genome Sequencing"},{"arc":[[39.8202781677246,-105.649436950684],[36.708869934082,-119.556427001953]],"countries":["United States"],"title":"Local Evolutionary Patterns of Human Respiratory Syncytial Virus Derived from Whole-Genome Sequencing"},{"arc":[[51.1218070983887,10.4006948471069],[40.7182693481445,46.4133987426758]],"countries":["Azerbaijan","Germany"],"title":"Imported Episodic Rabies Increases Patient Demand for and Physician Delivery of Antirabies Prophylaxis"},{"arc":[[42.8499984741211,-7.08333301544189],[35.7442817687988,127.166305541992]],"countries":["Spain","South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[42.8499984741211,-7.08333301544189],[36.7971878051758,127.704856872559]],"countries":["Spain","South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[42.8499984741211,-7.08333301544189],[36.662978,126.755133]],"countries":["Spain","South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[42.8499984741211,-7.08333301544189],[52.421459197998,-1.43792998790741]],"countries":["United Kingdom","Spain"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[42.8499984741211,-7.08333301544189],[31.3634490966797,75.5509414672852]],"countries":["Spain","India"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[42.8499984741211,-7.08333301544189],[33.511875,126.5585]],"countries":["Spain","South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[42.8499984741211,-7.08333301544189],[40.9437103271484,40.2619209289551]],"countries":["Turkey","Spain"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[42.8499984741211,-7.08333301544189],[35.386514,129.051233]],"countries":["Spain","South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[42.8499984741211,-7.08333301544189],[35.5382690429688,129.313323974609]],"countries":["Spain","South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[42.8499984741211,-7.08333301544189],[42.9547386169434,-78.8192367553711]],"countries":["United States","Spain"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[35.7442817687988,127.166305541992],[36.7971878051758,127.704856872559]],"countries":["South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[35.7442817687988,127.166305541992],[36.662978,126.755133]],"countries":["South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[35.7442817687988,127.166305541992],[52.421459197998,-1.43792998790741]],"countries":["United Kingdom","South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[35.7442817687988,127.166305541992],[31.3634490966797,75.5509414672852]],"countries":["South Korea","India"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[35.7442817687988,127.166305541992],[33.511875,126.5585]],"countries":["South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[35.7442817687988,127.166305541992],[40.9437103271484,40.2619209289551]],"countries":["Turkey","South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[35.7442817687988,127.166305541992],[35.386514,129.051233]],"countries":["South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[35.7442817687988,127.166305541992],[35.5382690429688,129.313323974609]],"countries":["South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[35.7442817687988,127.166305541992],[42.9547386169434,-78.8192367553711]],"countries":["United States","South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[36.7971878051758,127.704856872559],[36.662978,126.755133]],"countries":["South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[36.7971878051758,127.704856872559],[52.421459197998,-1.43792998790741]],"countries":["United Kingdom","South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[36.7971878051758,127.704856872559],[31.3634490966797,75.5509414672852]],"countries":["South Korea","India"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[36.7971878051758,127.704856872559],[33.511875,126.5585]],"countries":["South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[36.7971878051758,127.704856872559],[40.9437103271484,40.2619209289551]],"countries":["Turkey","South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[36.7971878051758,127.704856872559],[35.386514,129.051233]],"countries":["South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[36.7971878051758,127.704856872559],[35.5382690429688,129.313323974609]],"countries":["South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[36.7971878051758,127.704856872559],[42.9547386169434,-78.8192367553711]],"countries":["United States","South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[36.662978,126.755133],[36.662978,126.755133]],"countries":["South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[36.662978,126.755133],[52.421459197998,-1.43792998790741]],"countries":["United Kingdom","South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[36.662978,126.755133],[31.3634490966797,75.5509414672852]],"countries":["South Korea","India"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[36.662978,126.755133],[33.511875,126.5585]],"countries":["South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[36.662978,126.755133],[40.9437103271484,40.2619209289551]],"countries":["Turkey","South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[36.662978,126.755133],[35.386514,129.051233]],"countries":["South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[36.662978,126.755133],[35.5382690429688,129.313323974609]],"countries":["South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[36.662978,126.755133],[42.9547386169434,-78.8192367553711]],"countries":["United States","South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[52.421459197998,-1.43792998790741],[31.3634490966797,75.5509414672852]],"countries":["United Kingdom","India"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[52.421459197998,-1.43792998790741],[33.511875,126.5585]],"countries":["United Kingdom","South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[52.421459197998,-1.43792998790741],[40.9437103271484,40.2619209289551]],"countries":["United Kingdom","Turkey"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[52.421459197998,-1.43792998790741],[35.386514,129.051233]],"countries":["United Kingdom","South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[52.421459197998,-1.43792998790741],[35.5382690429688,129.313323974609]],"countries":["United Kingdom","South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[52.421459197998,-1.43792998790741],[42.9547386169434,-78.8192367553711]],"countries":["United Kingdom","United States"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[31.3634490966797,75.5509414672852],[33.511875,126.5585]],"countries":["South Korea","India"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[31.3634490966797,75.5509414672852],[40.9437103271484,40.2619209289551]],"countries":["Turkey","India"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[31.3634490966797,75.5509414672852],[35.386514,129.051233]],"countries":["India","South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[31.3634490966797,75.5509414672852],[35.5382690429688,129.313323974609]],"countries":["India","South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[31.3634490966797,75.5509414672852],[42.9547386169434,-78.8192367553711]],"countries":["United States","India"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[33.511875,126.5585],[40.9437103271484,40.2619209289551]],"countries":["Turkey","South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[33.511875,126.5585],[35.386514,129.051233]],"countries":["South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[33.511875,126.5585],[35.5382690429688,129.313323974609]],"countries":["South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[33.511875,126.5585],[42.9547386169434,-78.8192367553711]],"countries":["United States","South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[40.9437103271484,40.2619209289551],[35.386514,129.051233]],"countries":["Turkey","South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[40.9437103271484,40.2619209289551],[35.5382690429688,129.313323974609]],"countries":["Turkey","South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[40.9437103271484,40.2619209289551],[42.9547386169434,-78.8192367553711]],"countries":["Turkey","United States"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[40.9437103271484,40.2619209289551],[40.9437103271484,40.2619209289551]],"countries":["Turkey"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[35.386514,129.051233],[35.5382690429688,129.313323974609]],"countries":["South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[35.386514,129.051233],[42.9547386169434,-78.8192367553711]],"countries":["United States","South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[35.386514,129.051233],[40.9437103271484,40.2619209289551]],"countries":["Turkey","South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[35.5382690429688,129.313323974609],[42.9547386169434,-78.8192367553711]],"countries":["United States","South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[35.5382690429688,129.313323974609],[40.9437103271484,40.2619209289551]],"countries":["Turkey","South Korea"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[42.9547386169434,-78.8192367553711],[40.9437103271484,40.2619209289551]],"countries":["Turkey","United States"],"title":"Rapid Response Systems Reduce In-Hospital Cardiopulmonary Arrest: A Pilot Study and Motivation for a Nationwide Survey"},{"arc":[[35.876606,126.8157],[51.4559898376465,-0.24176000058651]],"countries":["South Korea","United Kingdom"],"title":"A Randomised Controlled Trial of Face Masks and Hand Hygiene in Reducing Influenza Transmission in Households"},{"arc":[[35.876606,126.8157],[22.2802925109863,114.142951965332]],"countries":["South Korea","Hong Kong SAR"],"title":"A Randomised Controlled Trial of Face Masks and Hand Hygiene in Reducing Influenza Transmission in Households"},{"arc":[[51.4559898376465,-0.24176000058651],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR","United Kingdom"],"title":"A Randomised Controlled Trial of Face Masks and Hand Hygiene in Reducing Influenza Transmission in Households"},{"arc":[[-12.3747396469116,130.874435424805],[-37.7949981689453,144.949722290039]],"countries":["Australia"],"title":"h  |                   "},{"arc":[[-12.3747396469116,130.874435424805],[-33.8895797729492,151.18212890625]],"countries":["Australia"],"title":"h  |                   "},{"arc":[[-37.7949981689453,144.949722290039],[-33.8895797729492,151.18212890625]],"countries":["Australia"],"title":"h  |                   "},{"arc":[[29.7095108032227,-95.3981781005859],[-37.7035598754883,145.180358886719]],"countries":["United States","Australia"],"title":"Heme Oxygenase-1-Expressing Dendritic Cells Promote Foxp3 + Regulatory T Cell Differentiation and Induce Less Severe Airway Inflammation in Murine Models"},{"arc":[[29.7095108032227,-95.3981781005859],[22.6201400756836,120.31226348877]],"countries":["United States","Taiwan"],"title":"Heme Oxygenase-1-Expressing Dendritic Cells Promote Foxp3 + Regulatory T Cell Differentiation and Induce Less Severe Airway Inflammation in Murine Models"},{"arc":[[-37.7035598754883,145.180358886719],[22.6201400756836,120.31226348877]],"countries":["Australia","Taiwan"],"title":"Heme Oxygenase-1-Expressing Dendritic Cells Promote Foxp3 + Regulatory T Cell Differentiation and Induce Less Severe Airway Inflammation in Murine Models"},{"arc":[[29.9536991119385,-90.077751159668],[45.5003509521484,-122.686950683594]],"countries":["United States"],"title":"Infectious vaccine-derived rubella viruses emerge, persist, and evolve in cutaneous granulomas of children with primary immunodeficiencies"},{"arc":[[29.9536991119385,-90.077751159668],[37.8056831359863,-122.268104553223]],"countries":["United States"],"title":"Infectious vaccine-derived rubella viruses emerge, persist, and evolve in cutaneous granulomas of children with primary immunodeficiencies"},{"arc":[[29.9536991119385,-90.077751159668],[39.0048141479492,-77.0975341796875]],"countries":["United States"],"title":"Infectious vaccine-derived rubella viruses emerge, persist, and evolve in cutaneous granulomas of children with primary immunodeficiencies"},{"arc":[[29.9536991119385,-90.077751159668],[41.8212890625,-71.412727355957]],"countries":["United States"],"title":"Infectious vaccine-derived rubella viruses emerge, persist, and evolve in cutaneous granulomas of children with primary immunodeficiencies"},{"arc":[[45.5003509521484,-122.686950683594],[37.8056831359863,-122.268104553223]],"countries":["United States"],"title":"Infectious vaccine-derived rubella viruses emerge, persist, and evolve in cutaneous granulomas of children with primary immunodeficiencies"},{"arc":[[45.5003509521484,-122.686950683594],[39.0048141479492,-77.0975341796875]],"countries":["United States"],"title":"Infectious vaccine-derived rubella viruses emerge, persist, and evolve in cutaneous granulomas of children with primary immunodeficiencies"},{"arc":[[45.5003509521484,-122.686950683594],[41.8212890625,-71.412727355957]],"countries":["United States"],"title":"Infectious vaccine-derived rubella viruses emerge, persist, and evolve in cutaneous granulomas of children with primary immunodeficiencies"},{"arc":[[37.8056831359863,-122.268104553223],[39.0048141479492,-77.0975341796875]],"countries":["United States"],"title":"Infectious vaccine-derived rubella viruses emerge, persist, and evolve in cutaneous granulomas of children with primary immunodeficiencies"},{"arc":[[37.8056831359863,-122.268104553223],[41.8212890625,-71.412727355957]],"countries":["United States"],"title":"Infectious vaccine-derived rubella viruses emerge, persist, and evolve in cutaneous granulomas of children with primary immunodeficiencies"},{"arc":[[39.0048141479492,-77.0975341796875],[41.8212890625,-71.412727355957]],"countries":["United States"],"title":"Infectious vaccine-derived rubella viruses emerge, persist, and evolve in cutaneous granulomas of children with primary immunodeficiencies"},{"arc":[[36.5631141662598,103.735809326172],[23.2024116516113,113.38606262207]],"countries":["China"],"title":"Isolation and characterization of a variant porcine epidemic diarrhea virus in China"},{"arc":[[36.5631141662598,103.735809326172],[44.3972511291504,-69.5694427490234]],"countries":["China","United States"],"title":"Isolation and characterization of a variant porcine epidemic diarrhea virus in China"},{"arc":[[23.2024116516113,113.38606262207],[23.2024116516113,113.38606262207]],"countries":["China"],"title":"Isolation and characterization of a variant porcine epidemic diarrhea virus in China"},{"arc":[[23.2024116516113,113.38606262207],[44.3972511291504,-69.5694427490234]],"countries":["China","United States"],"title":"Isolation and characterization of a variant porcine epidemic diarrhea virus in China"},{"arc":[[36.5631141662598,103.735809326172],[19.2065467834473,109.768585205078]],"countries":["China"],"title":"Tropical Medicine and Infectious Disease Endemic Melioidosis in Southern China: Past and Present"},{"arc":[[36.5631141662598,103.735809326172],[23.1312255859375,113.347915649414]],"countries":["China"],"title":"Tropical Medicine and Infectious Disease Endemic Melioidosis in Southern China: Past and Present"},{"arc":[[19.2065467834473,109.768585205078],[23.1312255859375,113.347915649414]],"countries":["China"],"title":"Tropical Medicine and Infectious Disease Endemic Melioidosis in Southern China: Past and Present"},{"arc":[[36.5631141662598,103.735809326172],[38.8350486755371,-77.3112411499023]],"countries":["China","United States"],"title":"Significant Prognostic Predictor for Patients with Severe Sepsis and Septic Shock"},{"arc":[[36.5631141662598,103.735809326172],[23.9117393493652,120.687438964844]],"countries":["China","Taiwan"],"title":"Significant Prognostic Predictor for Patients with Severe Sepsis and Septic Shock"},{"arc":[[36.5631141662598,103.735809326172],[41.8842506408691,-87.6324462890625]],"countries":["China","United States"],"title":"Significant Prognostic Predictor for Patients with Severe Sepsis and Septic Shock"},{"arc":[[38.8350486755371,-77.3112411499023],[23.9117393493652,120.687438964844]],"countries":["United States","Taiwan"],"title":"Significant Prognostic Predictor for Patients with Severe Sepsis and Septic Shock"},{"arc":[[38.8350486755371,-77.3112411499023],[41.8842506408691,-87.6324462890625]],"countries":["United States"],"title":"Significant Prognostic Predictor for Patients with Severe Sepsis and Septic Shock"},{"arc":[[23.9117393493652,120.687438964844],[41.8842506408691,-87.6324462890625]],"countries":["Taiwan","United States"],"title":"Significant Prognostic Predictor for Patients with Severe Sepsis and Septic Shock"},{"arc":[[40.9437103271484,40.2619209289551],[52.9340705871582,-1.20404005050659]],"countries":["Turkey","United Kingdom"],"title":"Global miRNA expression profiling of domestic cat livers following acute Toxoplasma gondii infection"},{"arc":[[40.9437103271484,40.2619209289551],[44.0889167785645,113.921737670898]],"countries":["Turkey","China"],"title":"Reverse Transcription Cross- Priming Amplification-Nucleic Acid Test Strip for Rapid Detection of Porcine Epidemic Diarrhea Virus OPEN"},{"arc":[[40.9437103271484,40.2619209289551],[30.6250877380371,102.697288513184]],"countries":["Turkey","China"],"title":"Reverse Transcription Cross- Priming Amplification-Nucleic Acid Test Strip for Rapid Detection of Porcine Epidemic Diarrhea Virus OPEN"},{"arc":[[40.9437103271484,40.2619209289551],[30.2741508483887,120.155151367188]],"countries":["Turkey","China"],"title":"Reverse Transcription Cross- Priming Amplification-Nucleic Acid Test Strip for Rapid Detection of Porcine Epidemic Diarrhea Virus OPEN"},{"arc":[[44.0889167785645,113.921737670898],[30.6250877380371,102.697288513184]],"countries":["China"],"title":"Reverse Transcription Cross- Priming Amplification-Nucleic Acid Test Strip for Rapid Detection of Porcine Epidemic Diarrhea Virus OPEN"},{"arc":[[44.0889167785645,113.921737670898],[30.2741508483887,120.155151367188]],"countries":["China"],"title":"Reverse Transcription Cross- Priming Amplification-Nucleic Acid Test Strip for Rapid Detection of Porcine Epidemic Diarrhea Virus OPEN"},{"arc":[[30.6250877380371,102.697288513184],[30.2741508483887,120.155151367188]],"countries":["China"],"title":"Reverse Transcription Cross- Priming Amplification-Nucleic Acid Test Strip for Rapid Detection of Porcine Epidemic Diarrhea Virus OPEN"},{"arc":[[40.9437103271484,40.2619209289551],[9.36855030059814,-83.6394882202148]],"countries":["Turkey","Costa Rica"],"title":"Mortality of COVID-19 is Associated with Cellular Immune Function Compared to Immune Function in Chinese Han Population"},{"arc":[[40.9437103271484,40.2619209289551],[39.0010192365134,-77.0841755726199]],"countries":["Turkey","United States"],"title":"Mortality of COVID-19 is Associated with Cellular Immune Function Compared to Immune Function in Chinese Han Population"},{"arc":[[9.36855030059814,-83.6394882202148],[39.0010192365134,-77.0841755726199]],"countries":["Costa Rica","United States"],"title":"Mortality of COVID-19 is Associated with Cellular Immune Function Compared to Immune Function in Chinese Han Population"},{"arc":[[39.9046897888184,116.407173156738],[44.3065299987793,86.0789337158203]],"countries":["China"],"title":"Activation of JNK1/2 and p38 MAPK signaling pathways promotes enterovirus 71 infection in immature dendritic cells"},{"arc":[[37.7697296142578,-122.466094970703],[60.1698989868164,24.9490509033203]],"countries":["United States","Finland"],"title":"Bid-deficient fish delay grass carp reovirus (GCRV) replication and attenuate GCRV-triggered apoptosis"},{"arc":[[37.7697296142578,-122.466094970703],[36.5631141662598,103.735809326172]],"countries":["China","United States"],"title":"Combined approaches of EPR and NMR illustrate only one transmembrane helix in the human IFITM3 OPEN"},{"arc":[[37.7697296142578,-122.466094970703],[28.7162494659424,77.2728576660156]],"countries":["United States","India"],"title":"An outbreak of cutaneous anthrax in Yunnan, China"},{"arc":[[37.7697296142578,-122.466094970703],[22.2802925109863,114.142951965332]],"countries":["United States","Hong Kong SAR"],"title":"An outbreak of cutaneous anthrax in Yunnan, China"},{"arc":[[37.7697296142578,-122.466094970703],[22.5732707977295,88.3621826171875]],"countries":["United States","India"],"title":"An outbreak of cutaneous anthrax in Yunnan, China"},{"arc":[[28.7162494659424,77.2728576660156],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR","India"],"title":"An outbreak of cutaneous anthrax in Yunnan, China"},{"arc":[[28.7162494659424,77.2728576660156],[22.5732707977295,88.3621826171875]],"countries":["India"],"title":"An outbreak of cutaneous anthrax in Yunnan, China"},{"arc":[[22.2802925109863,114.142951965332],[22.5732707977295,88.3621826171875]],"countries":["Hong Kong SAR","India"],"title":"An outbreak of cutaneous anthrax in Yunnan, China"},{"arc":[[37.7697296142578,-122.466094970703],[30.6250877380371,102.697288513184]],"countries":["United States","China"],"title":"Molecular basis of binding between the global post-transcriptional regulator CsrA and the T3SS chaperone CesT"},{"arc":[[37.7697296142578,-122.466094970703],[44.3972511291504,-69.5694427490234]],"countries":["United States"],"title":"Molecular basis of binding between the global post-transcriptional regulator CsrA and the T3SS chaperone CesT"},{"arc":[[30.6250877380371,102.697288513184],[44.3972511291504,-69.5694427490234]],"countries":["China","United States"],"title":"Molecular basis of binding between the global post-transcriptional regulator CsrA and the T3SS chaperone CesT"},{"arc":[[37.7697296142578,-122.466094970703],[40.9437103271484,40.2619209289551]],"countries":["Turkey","United States"],"title":"Protection against homo and hetero-subtypic influenza A virus by optimized M2e DNA vaccine"},{"arc":[[37.7697296142578,-122.466094970703],[30.5927600860596,114.305252075195]],"countries":["United States","China"],"title":"Protection against homo and hetero-subtypic influenza A virus by optimized M2e DNA vaccine"},{"arc":[[40.9437103271484,40.2619209289551],[30.5927600860596,114.305252075195]],"countries":["Turkey","China"],"title":"Protection against homo and hetero-subtypic influenza A virus by optimized M2e DNA vaccine"},{"arc":[[35.9628207555179,-88.9393164950906],[9.36855030059814,-83.6394882202148]],"countries":["United States","Costa Rica"],"title":"Therapeutics and Clinical Risk Management Dovepress Frequency of tuberculosis among diabetic patients in the People's Republic of China"},{"arc":[[35.9628207555179,-88.9393164950906],[41.7278709411621,44.764778137207]],"countries":["Georgia","United States"],"title":"Therapeutics and Clinical Risk Management Dovepress Frequency of tuberculosis among diabetic patients in the People's Republic of China"},{"arc":[[9.36855030059814,-83.6394882202148],[41.7278709411621,44.764778137207]],"countries":["Georgia","Costa Rica"],"title":"Therapeutics and Clinical Risk Management Dovepress Frequency of tuberculosis among diabetic patients in the People's Republic of China"},{"arc":[[29.5647106170654,106.550727844238],[39.9925537109375,116.310485839844]],"countries":["China"],"title":"Epidemiology of human adenovirus and molecular characterization of human adenovirus 55 in China"},{"arc":[[29.5647106170654,106.550727844238],[44.9734497070312,-93.2378997802734]],"countries":["China","United States"],"title":"Epidemiology of human adenovirus and molecular characterization of human adenovirus 55 in China"},{"arc":[[39.9925537109375,116.310485839844],[44.9734497070312,-93.2378997802734]],"countries":["China","United States"],"title":"Epidemiology of human adenovirus and molecular characterization of human adenovirus 55 in China"},{"arc":[[48.8221206665039,2.33101010322571],[29.649730682373,-82.3411331176758]],"countries":["France","United States"],"title":"Complete Genome Sequence of Human Coronavirus Strain 229E Isolated from Plasma Collected from a Haitian Child in 2016"},{"arc":[[35.856219,126.988803],[36.662978,126.755133]],"countries":["South Korea"],"title":"Label-Free Electrochemical Diagnosis of Viral Antigens with Genetically Engineered Fusion Protein"},{"arc":[[35.856219,126.988803],[26.8637504577637,78.9172210693359]],"countries":["South Korea","India"],"title":"Label-Free Electrochemical Diagnosis of Viral Antigens with Genetically Engineered Fusion Protein"},{"arc":[[35.856219,126.988803],[46.9460830688477,7.43722105026245]],"countries":["South Korea","Switzerland"],"title":"Label-Free Electrochemical Diagnosis of Viral Antigens with Genetically Engineered Fusion Protein"},{"arc":[[36.662978,126.755133],[26.8637504577637,78.9172210693359]],"countries":["South Korea","India"],"title":"Label-Free Electrochemical Diagnosis of Viral Antigens with Genetically Engineered Fusion Protein"},{"arc":[[36.662978,126.755133],[46.9460830688477,7.43722105026245]],"countries":["South Korea","Switzerland"],"title":"Label-Free Electrochemical Diagnosis of Viral Antigens with Genetically Engineered Fusion Protein"},{"arc":[[26.8637504577637,78.9172210693359],[46.9460830688477,7.43722105026245]],"countries":["Switzerland","India"],"title":"Label-Free Electrochemical Diagnosis of Viral Antigens with Genetically Engineered Fusion Protein"},{"arc":[[39.1410217285156,-84.5021362304688],[-25.4304790496826,-49.2845115661621]],"countries":["United States","Brazil"],"title":"Preliminary epidemiological analysis on children and adolescents with novel coronavirus disease 2019 outside Hubei Province, China: an observational study utilizing crowdsourced data"},{"arc":[[41.5047302246094,-81.6907424926758],[51.1218070983887,10.4006948471069]],"countries":["Germany","United States"],"title":"Evasion of Antiviral Innate Immunity by Theiler's Virus L* Protein through Direct Inhibition of RNase L"},{"arc":[[30.7602596282959,47.6596298217773],[33.5566825866699,23.774206161499]],"countries":["Iraq","NOCOUNTRY"],"title":"Detection of Plant DNA in the Bronchoalveolar Lavage of Patients with Ventilator-Associated Pneumonia"},{"arc":[[39.6785011291504,-104.966621398926],[37.6757011413574,-121.758560180664]],"countries":["United States"],"title":"Middle East Respiratory Syndrome Coronavirus Intra-Host Populations Are Characterized by Numerous High Frequency Variants"},{"arc":[[40.8081588745117,-73.9636535644531],[40.8075561523438,-73.9640808105469]],"countries":["United States"],"title":"Stress-induced phospho-ubiquitin formation causes parkin degradation"},{"arc":[[40.8081588745117,-73.9636535644531],[42.9370803833008,-75.6106948852539]],"countries":["United States"],"title":"Stress-induced phospho-ubiquitin formation causes parkin degradation"},{"arc":[[40.8075561523438,-73.9640808105469],[42.9370803833008,-75.6106948852539]],"countries":["United States"],"title":"Stress-induced phospho-ubiquitin formation causes parkin degradation"},{"arc":[[47.4847412109375,1.68438005447388],[1.32175004482269,103.846237182617]],"countries":["France","Singapore"],"title":"Severe Acute Respiratory Syndrome (SARS) in Singapore: Clinical Features of Index Patient and Initial Contacts"},{"arc":[[51.88564,-8.53312],[41.750358581543,-72.6930084228516]],"countries":["Ireland","United States"],"title":"BMC Veterinary Research Molecular characterisation of a bovine-like rotavirus detected from a giraffe"},{"arc":[[51.88564,-8.53312],[53.3086013793945,-6.22065019607544]],"countries":["Ireland"],"title":"BMC Veterinary Research Molecular characterisation of a bovine-like rotavirus detected from a giraffe"},{"arc":[[41.750358581543,-72.6930084228516],[53.3086013793945,-6.22065019607544]],"countries":["United States","Ireland"],"title":"BMC Veterinary Research Molecular characterisation of a bovine-like rotavirus detected from a giraffe"},{"arc":[[52.2457656860352,5.56521511077881],[42.95438,-74.19623]],"countries":["Netherlands","United States"],"title":"Generation of stable monoclonal antibody-producing BCR + human memory B cells by genetic programming Supplementary Figures 1-2 Supplementary Methods Supplementary Reference"},{"arc":[[44.6344795227051,-63.5939788818359],[13.0170698165894,77.6431198120117]],"countries":["Canada","India"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[44.6344795227051,-63.5939788818359],[43.9649963378906,-112.343688964844]],"countries":["Canada","NOCOUNTRY"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[44.6344795227051,-63.5939788818359],[23.3535003662109,116.68221282959]],"countries":["Canada","China"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[44.6344795227051,-63.5939788818359],[40.72495,8.56011]],"countries":["Canada","Italy"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[44.6344795227051,-63.5939788818359],[35.7868995666504,-93.9436416625977]],"countries":["United States","Canada"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[44.6344795227051,-63.5939788818359],[49.8096008300781,-97.1333312988281]],"countries":["Canada"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[44.6344795227051,-63.5939788818359],[52.1374397277832,-106.627517700195]],"countries":["Canada"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[13.0170698165894,77.6431198120117],[43.9649963378906,-112.343688964844]],"countries":["India","NOCOUNTRY"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[13.0170698165894,77.6431198120117],[23.3535003662109,116.68221282959]],"countries":["India","China"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[13.0170698165894,77.6431198120117],[40.72495,8.56011]],"countries":["India","Italy"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[13.0170698165894,77.6431198120117],[35.7868995666504,-93.9436416625977]],"countries":["United States","India"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[13.0170698165894,77.6431198120117],[49.8096008300781,-97.1333312988281]],"countries":["India","Canada"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[13.0170698165894,77.6431198120117],[52.1374397277832,-106.627517700195]],"countries":["India","Canada"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[43.9649963378906,-112.343688964844],[23.3535003662109,116.68221282959]],"countries":["China","NOCOUNTRY"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[43.9649963378906,-112.343688964844],[40.72495,8.56011]],"countries":["NOCOUNTRY","Italy"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[43.9649963378906,-112.343688964844],[35.7868995666504,-93.9436416625977]],"countries":["United States","NOCOUNTRY"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[43.9649963378906,-112.343688964844],[49.8096008300781,-97.1333312988281]],"countries":["NOCOUNTRY","Canada"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[43.9649963378906,-112.343688964844],[52.1374397277832,-106.627517700195]],"countries":["NOCOUNTRY","Canada"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[23.3535003662109,116.68221282959],[40.72495,8.56011]],"countries":["China","Italy"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[23.3535003662109,116.68221282959],[35.7868995666504,-93.9436416625977]],"countries":["United States","China"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[23.3535003662109,116.68221282959],[49.8096008300781,-97.1333312988281]],"countries":["China","Canada"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[23.3535003662109,116.68221282959],[52.1374397277832,-106.627517700195]],"countries":["China","Canada"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[40.72495,8.56011],[35.7868995666504,-93.9436416625977]],"countries":["United States","Italy"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[40.72495,8.56011],[49.8096008300781,-97.1333312988281]],"countries":["Italy","Canada"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[40.72495,8.56011],[52.1374397277832,-106.627517700195]],"countries":["Italy","Canada"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[35.7868995666504,-93.9436416625977],[49.8096008300781,-97.1333312988281]],"countries":["United States","Canada"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[35.7868995666504,-93.9436416625977],[52.1374397277832,-106.627517700195]],"countries":["United States","Canada"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[49.8096008300781,-97.1333312988281],[52.1374397277832,-106.627517700195]],"countries":["Canada"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[45.6480598449707,-76.3253326416016],[32.9052963256836,-117.243560791016]],"countries":["Canada","United States"],"title":"Teacher led school-based surveillance can allow accurate tracking of emerging infectious diseases -evidence from serial cross-sectional surveys of febrile respiratory illness during the H1N1 2009 influenza pandemic in Singapore"},{"arc":[[45.6480598449707,-76.3253326416016],[1.29718005657196,103.77774810791]],"countries":["Canada","Singapore"],"title":"Teacher led school-based surveillance can allow accurate tracking of emerging infectious diseases -evidence from serial cross-sectional surveys of febrile respiratory illness during the H1N1 2009 influenza pandemic in Singapore"},{"arc":[[32.9052963256836,-117.243560791016],[1.29718005657196,103.77774810791]],"countries":["Singapore","United States"],"title":"Teacher led school-based surveillance can allow accurate tracking of emerging infectious diseases -evidence from serial cross-sectional surveys of febrile respiratory illness during the H1N1 2009 influenza pandemic in Singapore"},{"arc":[[36.0000915527344,-78.9306488037109],[22.3796997070312,114.201698303223]],"countries":["United States","Hong Kong SAR"],"title":"A Mini Review of the Zoonotic Threat Potential of influenza viruses, Coronaviruses, Adenoviruses, and enteroviruses"},{"arc":[[40.9215507507324,-81.105842590332],[41.6771812438965,123.463096618652]],"countries":["China","United States"],"title":"Discovery of Diverse Rodent and Bat Pestiviruses With Distinct Genomic and Phylogenetic Characteristics in Several Chinese Provinces"},{"arc":[[40.9215507507324,-81.105842590332],[8.51776,76.94091]],"countries":["United States","India"],"title":"Discovery of Diverse Rodent and Bat Pestiviruses With Distinct Genomic and Phylogenetic Characteristics in Several Chinese Provinces"},{"arc":[[40.9215507507324,-81.105842590332],[44.9734497070312,-93.2378997802734]],"countries":["United States"],"title":"Discovery of Diverse Rodent and Bat Pestiviruses With Distinct Genomic and Phylogenetic Characteristics in Several Chinese Provinces"},{"arc":[[41.6771812438965,123.463096618652],[8.51776,76.94091]],"countries":["China","India"],"title":"Discovery of Diverse Rodent and Bat Pestiviruses With Distinct Genomic and Phylogenetic Characteristics in Several Chinese Provinces"},{"arc":[[41.6771812438965,123.463096618652],[44.9734497070312,-93.2378997802734]],"countries":["China","United States"],"title":"Discovery of Diverse Rodent and Bat Pestiviruses With Distinct Genomic and Phylogenetic Characteristics in Several Chinese Provinces"},{"arc":[[8.51776,76.94091],[44.9734497070312,-93.2378997802734]],"countries":["India","United States"],"title":"Discovery of Diverse Rodent and Bat Pestiviruses With Distinct Genomic and Phylogenetic Characteristics in Several Chinese Provinces"},{"arc":[[4.58086013793945,-74.4432830810547],[0.335489988327026,32.5687217712402]],"countries":["Colombia","Uganda"],"title":"Applying evolutionary concepts to wildlife disease ecology and management"},{"arc":[[4.58086013793945,-74.4432830810547],[45.5065994262695,-73.5779571533203]],"countries":["Colombia","Canada"],"title":"Applying evolutionary concepts to wildlife disease ecology and management"},{"arc":[[0.335489988327026,32.5687217712402],[45.5065994262695,-73.5779571533203]],"countries":["Uganda","Canada"],"title":"Applying evolutionary concepts to wildlife disease ecology and management"},{"arc":[[33.789680480957,-84.3255462646484],[46.7281913757324,-117.006896972656]],"countries":["United States"],"title":"Recombinant vector vaccines and within-host evolution 1"},{"arc":[[33.7483100891113,-84.39111328125],[40.9437103271484,40.2619209289551]],"countries":["Turkey","United States"],"title":"Detection of Novel SARS-like and Other Coronaviruses in Bats from Kenya"},{"arc":[[33.7483100891113,-84.39111328125],[0.537028014659882,37.8567771911621]],"countries":["United States","Kenya"],"title":"Detection of Novel SARS-like and Other Coronaviruses in Bats from Kenya"},{"arc":[[33.7483100891113,-84.39111328125],[39.4959106445312,-98.9899826049805]],"countries":["United States"],"title":"Detection of Novel SARS-like and Other Coronaviruses in Bats from Kenya"},{"arc":[[40.9437103271484,40.2619209289551],[0.537028014659882,37.8567771911621]],"countries":["Turkey","Kenya"],"title":"Detection of Novel SARS-like and Other Coronaviruses in Bats from Kenya"},{"arc":[[40.9437103271484,40.2619209289551],[39.4959106445312,-98.9899826049805]],"countries":["Turkey","United States"],"title":"Detection of Novel SARS-like and Other Coronaviruses in Bats from Kenya"},{"arc":[[0.537028014659882,37.8567771911621],[39.4959106445312,-98.9899826049805]],"countries":["United States","Kenya"],"title":"Detection of Novel SARS-like and Other Coronaviruses in Bats from Kenya"},{"arc":[[51.9100685119629,4.46534013748169],[50.5807495117188,8.67675018310547]],"countries":["Netherlands","Germany"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[51.9100685119629,4.46534013748169],[52.1658325195312,4.47749996185303]],"countries":["Netherlands"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[51.9100685119629,4.46534013748169],[55.6972007751465,37.5378494262695]],"countries":["Netherlands","Russia"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[51.9100685119629,4.46534013748169],[41.9982795715332,-87.6571731567383]],"countries":["Netherlands","United States"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[51.9100685119629,4.46534013748169],[50.7338905334473,7.10222196578979]],"countries":["Netherlands","Germany"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[51.9100685119629,4.46534013748169],[38.987850189209,-76.9389038085938]],"countries":["Netherlands","United States"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[51.9100685119629,4.46534013748169],[51.4414596557617,-0.947839975357056]],"countries":["Netherlands","United Kingdom"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[51.9100685119629,4.46534013748169],[52.08896,5.1784]],"countries":["Netherlands"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[50.5807495117188,8.67675018310547],[52.1658325195312,4.47749996185303]],"countries":["Germany","Netherlands"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[50.5807495117188,8.67675018310547],[55.6972007751465,37.5378494262695]],"countries":["Germany","Russia"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[50.5807495117188,8.67675018310547],[41.9982795715332,-87.6571731567383]],"countries":["Germany","United States"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[50.5807495117188,8.67675018310547],[50.7338905334473,7.10222196578979]],"countries":["Germany"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[50.5807495117188,8.67675018310547],[38.987850189209,-76.9389038085938]],"countries":["Germany","United States"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[50.5807495117188,8.67675018310547],[51.4414596557617,-0.947839975357056]],"countries":["Germany","United Kingdom"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[50.5807495117188,8.67675018310547],[52.08896,5.1784]],"countries":["Germany","Netherlands"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[52.1658325195312,4.47749996185303],[55.6972007751465,37.5378494262695]],"countries":["Netherlands","Russia"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[52.1658325195312,4.47749996185303],[41.9982795715332,-87.6571731567383]],"countries":["Netherlands","United States"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[52.1658325195312,4.47749996185303],[50.7338905334473,7.10222196578979]],"countries":["Netherlands","Germany"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[52.1658325195312,4.47749996185303],[38.987850189209,-76.9389038085938]],"countries":["Netherlands","United States"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[52.1658325195312,4.47749996185303],[51.4414596557617,-0.947839975357056]],"countries":["Netherlands","United Kingdom"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[52.1658325195312,4.47749996185303],[52.08896,5.1784]],"countries":["Netherlands"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[55.6972007751465,37.5378494262695],[41.9982795715332,-87.6571731567383]],"countries":["Russia","United States"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[55.6972007751465,37.5378494262695],[50.7338905334473,7.10222196578979]],"countries":["Russia","Germany"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[55.6972007751465,37.5378494262695],[38.987850189209,-76.9389038085938]],"countries":["Russia","United States"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[55.6972007751465,37.5378494262695],[51.4414596557617,-0.947839975357056]],"countries":["Russia","United Kingdom"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[55.6972007751465,37.5378494262695],[52.08896,5.1784]],"countries":["Russia","Netherlands"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[41.9982795715332,-87.6571731567383],[50.7338905334473,7.10222196578979]],"countries":["United States","Germany"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[41.9982795715332,-87.6571731567383],[38.987850189209,-76.9389038085938]],"countries":["United States"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[41.9982795715332,-87.6571731567383],[51.4414596557617,-0.947839975357056]],"countries":["United States","United Kingdom"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[41.9982795715332,-87.6571731567383],[52.08896,5.1784]],"countries":["United States","Netherlands"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[50.7338905334473,7.10222196578979],[38.987850189209,-76.9389038085938]],"countries":["Germany","United States"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[50.7338905334473,7.10222196578979],[51.4414596557617,-0.947839975357056]],"countries":["Germany","United Kingdom"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[50.7338905334473,7.10222196578979],[52.08896,5.1784]],"countries":["Germany","Netherlands"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[38.987850189209,-76.9389038085938],[51.4414596557617,-0.947839975357056]],"countries":["United States","United Kingdom"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[38.987850189209,-76.9389038085938],[52.08896,5.1784]],"countries":["United States","Netherlands"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[51.4414596557617,-0.947839975357056],[52.08896,5.1784]],"countries":["United Kingdom","Netherlands"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[51.9100685119629,4.46534013748169],[-27.6047096252441,151.929931640625]],"countries":["Netherlands","Australia"],"title":"SARS Risk Perception, Knowledge, Precautions, and Information Sources, the Netherlands"},{"arc":[[42.9547386169434,-78.8192367553711],[42.9547386169434,-78.8192367553711]],"countries":["United States"],"title":"Chaperna-Mediated Assembly of Ferritin-Based Middle East Respiratory Syndrome-Coronavirus Nanoparticles"},{"arc":[[-5.80592012405396,-35.2105407714844],[-23.5594444274902,-46.7238883972168]],"countries":["Brazil","NOCOUNTRY"],"title":"Chloroquine Inhibits Dengue Virus Type 2 Replication in Vero Cells but Not in C6/36 Cells"},{"arc":[[45.4600639343262,9.19467735290527],[41.9090461730957,12.5119895935059]],"countries":["Italy"],"title":"Bocavirus Infection in Otherwise Healthy Children with Respiratory Disease"},{"arc":[[45.4600639343262,9.19467735290527],[45.467960357666,9.1817798614502]],"countries":["Italy"],"title":"Bocavirus Infection in Otherwise Healthy Children with Respiratory Disease"},{"arc":[[45.4600639343262,9.19467735290527],[43.0953407287598,12.5024099349976]],"countries":["Italy"],"title":"Bocavirus Infection in Otherwise Healthy Children with Respiratory Disease"},{"arc":[[41.9090461730957,12.5119895935059],[45.467960357666,9.1817798614502]],"countries":["Italy"],"title":"Bocavirus Infection in Otherwise Healthy Children with Respiratory Disease"},{"arc":[[41.9090461730957,12.5119895935059],[43.0953407287598,12.5024099349976]],"countries":["Italy"],"title":"Bocavirus Infection in Otherwise Healthy Children with Respiratory Disease"},{"arc":[[45.467960357666,9.1817798614502],[43.0953407287598,12.5024099349976]],"countries":["Italy"],"title":"Bocavirus Infection in Otherwise Healthy Children with Respiratory Disease"},{"arc":[[38.0572509765625,-97.9326782226562],[39.527660369873,-119.813529968262]],"countries":["United States"],"title":"Transgenic mice expressing tunable levels of DUX4 develop characteristic facioscapulohumeral muscular dystrophy-like pathophysiology ranging in severity Title: FSHD-like transgenic mouse models of varying severity"},{"arc":[[44.2833099365234,12.3498802185059],[47.999195098877,7.84813022613525]],"countries":["Italy","Germany"],"title":"USP18 -a multifunctional component in the interferon response"},{"arc":[[31.2988891601562,121.499168395996],[54.0102615356445,-2.78708004951477]],"countries":["China","United Kingdom"],"title":"Patterns of human social contact and contact with animals in Shanghai, China"},{"arc":[[31.2988891601562,121.499168395996],[22.2802925109863,114.142951965332]],"countries":["China","Hong Kong SAR"],"title":"Patterns of human social contact and contact with animals in Shanghai, China"},{"arc":[[54.0102615356445,-2.78708004951477],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR","United Kingdom"],"title":"Patterns of human social contact and contact with animals in Shanghai, China"},{"arc":[[31.2988891601562,121.499168395996],[36.5042343139648,138.984161376953]],"countries":["China","Japan"],"title":"Development of Monoclonal Antibody and Diagnostic Test for Middle East Respiratory Syndrome Coronavirus Using Cell-Free Synthesized Nucleocapsid Antigen Development of a Diagnostic Test for MERS-CoV"},{"arc":[[31.2988891601562,121.499168395996],[24.9809303283691,93.8902435302734]],"countries":["China","India"],"title":"Development of Monoclonal Antibody and Diagnostic Test for Middle East Respiratory Syndrome Coronavirus Using Cell-Free Synthesized Nucleocapsid Antigen Development of a Diagnostic Test for MERS-CoV"},{"arc":[[31.2988891601562,121.499168395996],[40.9437103271484,40.2619209289551]],"countries":["Turkey","China"],"title":"Development of Monoclonal Antibody and Diagnostic Test for Middle East Respiratory Syndrome Coronavirus Using Cell-Free Synthesized Nucleocapsid Antigen Development of a Diagnostic Test for MERS-CoV"},{"arc":[[31.2988891601562,121.499168395996],[35.4666900634766,139.621841430664]],"countries":["China","Japan"],"title":"Development of Monoclonal Antibody and Diagnostic Test for Middle East Respiratory Syndrome Coronavirus Using Cell-Free Synthesized Nucleocapsid Antigen Development of a Diagnostic Test for MERS-CoV"},{"arc":[[36.5042343139648,138.984161376953],[24.9809303283691,93.8902435302734]],"countries":["Japan","India"],"title":"Development of Monoclonal Antibody and Diagnostic Test for Middle East Respiratory Syndrome Coronavirus Using Cell-Free Synthesized Nucleocapsid Antigen Development of a Diagnostic Test for MERS-CoV"},{"arc":[[36.5042343139648,138.984161376953],[40.9437103271484,40.2619209289551]],"countries":["Turkey","Japan"],"title":"Development of Monoclonal Antibody and Diagnostic Test for Middle East Respiratory Syndrome Coronavirus Using Cell-Free Synthesized Nucleocapsid Antigen Development of a Diagnostic Test for MERS-CoV"},{"arc":[[36.5042343139648,138.984161376953],[35.4666900634766,139.621841430664]],"countries":["Japan"],"title":"Development of Monoclonal Antibody and Diagnostic Test for Middle East Respiratory Syndrome Coronavirus Using Cell-Free Synthesized Nucleocapsid Antigen Development of a Diagnostic Test for MERS-CoV"},{"arc":[[24.9809303283691,93.8902435302734],[40.9437103271484,40.2619209289551]],"countries":["Turkey","India"],"title":"Development of Monoclonal Antibody and Diagnostic Test for Middle East Respiratory Syndrome Coronavirus Using Cell-Free Synthesized Nucleocapsid Antigen Development of a Diagnostic Test for MERS-CoV"},{"arc":[[24.9809303283691,93.8902435302734],[35.4666900634766,139.621841430664]],"countries":["India","Japan"],"title":"Development of Monoclonal Antibody and Diagnostic Test for Middle East Respiratory Syndrome Coronavirus Using Cell-Free Synthesized Nucleocapsid Antigen Development of a Diagnostic Test for MERS-CoV"},{"arc":[[40.9437103271484,40.2619209289551],[35.4666900634766,139.621841430664]],"countries":["Turkey","Japan"],"title":"Development of Monoclonal Antibody and Diagnostic Test for Middle East Respiratory Syndrome Coronavirus Using Cell-Free Synthesized Nucleocapsid Antigen Development of a Diagnostic Test for MERS-CoV"},{"arc":[[35.4666900634766,139.621841430664],[35.4666900634766,139.621841430664]],"countries":["Japan"],"title":"Development of Monoclonal Antibody and Diagnostic Test for Middle East Respiratory Syndrome Coronavirus Using Cell-Free Synthesized Nucleocapsid Antigen Development of a Diagnostic Test for MERS-CoV"},{"arc":[[26.029390335083,118.138877868652],[31.0254402160645,121.436302185059]],"countries":["China"],"title":"Glucocorticosteroid in Treatment of Severe Pneumonia"},{"arc":[[26.029390335083,118.138877868652],[31.2148895263672,121.564643859863]],"countries":["China"],"title":"Glucocorticosteroid in Treatment of Severe Pneumonia"},{"arc":[[31.0254402160645,121.436302185059],[31.2148895263672,121.564643859863]],"countries":["China"],"title":"Glucocorticosteroid in Treatment of Severe Pneumonia"},{"arc":[[45.2616806030273,4.67889022827148],[36.755867,126.30135]],"countries":["France","South Korea"],"title":"Airflow analysis of Pyeongtaek St Mary's Hospital during hospitalization of the first Middle East respiratory syndrome patient in Korea"},{"arc":[[45.2616806030273,4.67889022827148],[14.477560043335,120.89826965332]],"countries":["Philippines","France"],"title":"Airflow analysis of Pyeongtaek St Mary's Hospital during hospitalization of the first Middle East respiratory syndrome patient in Korea"},{"arc":[[45.2616806030273,4.67889022827148],[36.532703,127.252875]],"countries":["France","South Korea"],"title":"Airflow analysis of Pyeongtaek St Mary's Hospital during hospitalization of the first Middle East respiratory syndrome patient in Korea"},{"arc":[[36.755867,126.30135],[14.477560043335,120.89826965332]],"countries":["Philippines","South Korea"],"title":"Airflow analysis of Pyeongtaek St Mary's Hospital during hospitalization of the first Middle East respiratory syndrome patient in Korea"},{"arc":[[36.755867,126.30135],[36.532703,127.252875]],"countries":["South Korea"],"title":"Airflow analysis of Pyeongtaek St Mary's Hospital during hospitalization of the first Middle East respiratory syndrome patient in Korea"},{"arc":[[14.477560043335,120.89826965332],[36.532703,127.252875]],"countries":["Philippines","South Korea"],"title":"Airflow analysis of Pyeongtaek St Mary's Hospital during hospitalization of the first Middle East respiratory syndrome patient in Korea"},{"arc":[[1.29041004180908,103.852111816406],[27.6073627471924,111.713684082031]],"countries":["China","Singapore"],"title":"A cascade reaction network mimicking the basic functional steps of acquired immune response"},{"arc":[[1.29041004180908,103.852111816406],[45.188892364502,-91.2747573852539]],"countries":["Singapore","United States"],"title":"A cascade reaction network mimicking the basic functional steps of acquired immune response"},{"arc":[[1.29041004180908,103.852111816406],[29.649730682373,-82.3411331176758]],"countries":["Singapore","United States"],"title":"A cascade reaction network mimicking the basic functional steps of acquired immune response"},{"arc":[[27.6073627471924,111.713684082031],[45.188892364502,-91.2747573852539]],"countries":["China","United States"],"title":"A cascade reaction network mimicking the basic functional steps of acquired immune response"},{"arc":[[27.6073627471924,111.713684082031],[29.649730682373,-82.3411331176758]],"countries":["China","United States"],"title":"A cascade reaction network mimicking the basic functional steps of acquired immune response"},{"arc":[[45.188892364502,-91.2747573852539],[29.649730682373,-82.3411331176758]],"countries":["United States"],"title":"A cascade reaction network mimicking the basic functional steps of acquired immune response"},{"arc":[[32.6483306884766,-83.4445571899414],[35.3076782226562,-93.8832092285156]],"countries":["United States"],"title":"Complete Genome Sequence of Avian Coronavirus Strain GA08 (GI-27 Lineage)"},{"arc":[[32.6483306884766,-83.4445571899414],[53.4570770263672,27.2214450836182]],"countries":["United States","Belarus"],"title":"Complete Genome Sequence of Avian Coronavirus Strain GA08 (GI-27 Lineage)"},{"arc":[[35.3076782226562,-93.8832092285156],[53.4570770263672,27.2214450836182]],"countries":["United States","Belarus"],"title":"Complete Genome Sequence of Avian Coronavirus Strain GA08 (GI-27 Lineage)"},{"arc":[[36.0004425048828,-78.9623413085938],[52.2593307495117,-109.820449829102]],"countries":["United States","Canada"],"title":"Analysis of IFITM-IFITM Interactions by a Flow Cytometry-Based FRET Assay"},{"arc":[[-25.1099891662598,30.7521800994873],[45.7594299316406,4.82885980606079]],"countries":["South Africa","France"],"title":"Drug Repurposing Approaches for the Treatment of Influenza Viral Infection: Reviving Old Drugs to Fight Against a Long-Lived Enemy"},{"arc":[[-25.1099891662598,30.7521800994873],[45.7491493225098,4.83716011047363]],"countries":["South Africa","France"],"title":"Drug Repurposing Approaches for the Treatment of Influenza Viral Infection: Reviving Old Drugs to Fight Against a Long-Lived Enemy"},{"arc":[[45.7594299316406,4.82885980606079],[45.7491493225098,4.83716011047363]],"countries":["France"],"title":"Drug Repurposing Approaches for the Treatment of Influenza Viral Infection: Reviving Old Drugs to Fight Against a Long-Lived Enemy"},{"arc":[[-27.5583305358887,153.051071166992],[-37.7035598754883,145.180358886719]],"countries":["Australia"],"title":"Role of Pentraxin 3 in Shaping Arthritogenic Alphaviral Disease: From Enhanced Viral Replication to Immunomodulation"},{"arc":[[-27.5583305358887,153.051071166992],[1.29041004180908,103.852111816406]],"countries":["Singapore","Australia"],"title":"Role of Pentraxin 3 in Shaping Arthritogenic Alphaviral Disease: From Enhanced Viral Replication to Immunomodulation"},{"arc":[[-27.5583305358887,153.051071166992],[-37.797981262207,144.959045410156]],"countries":["Australia"],"title":"Role of Pentraxin 3 in Shaping Arthritogenic Alphaviral Disease: From Enhanced Viral Replication to Immunomodulation"},{"arc":[[-37.7035598754883,145.180358886719],[1.29041004180908,103.852111816406]],"countries":["Australia","Singapore"],"title":"Role of Pentraxin 3 in Shaping Arthritogenic Alphaviral Disease: From Enhanced Viral Replication to Immunomodulation"},{"arc":[[-37.7035598754883,145.180358886719],[-37.797981262207,144.959045410156]],"countries":["Australia"],"title":"Role of Pentraxin 3 in Shaping Arthritogenic Alphaviral Disease: From Enhanced Viral Replication to Immunomodulation"},{"arc":[[1.29041004180908,103.852111816406],[-37.797981262207,144.959045410156]],"countries":["Singapore","Australia"],"title":"Role of Pentraxin 3 in Shaping Arthritogenic Alphaviral Disease: From Enhanced Viral Replication to Immunomodulation"},{"arc":[[23.8029747009277,108.794311523438],[37.4599990844727,126.949996948242]],"countries":["China","South Korea"],"title":"Molecular Characterization of Major Structural Protein Genes of Avian Coronavirus Infectious Bronchitis Virus Isolates in Southern China"},{"arc":[[22.5713901519775,88.3903274536133],[22.49587059021,88.3711624145508]],"countries":["India"],"title":"Strategies for vaccine design for corona virus using Immunoinformatics techniques"},{"arc":[[38.713264465332,-85.458740234375],[34.0321617126465,-84.581298828125]],"countries":["United States"],"title":"Kinetic Analysis of Bacteriophage Sf6 Binding to Outer Membrane Protein A Using Whole Virions"},{"arc":[[42.373161315918,-71.1181182861328],[42.373161315918,-71.1181182861328]],"countries":["United States"],"title":"Quantifying the success of measles vaccination campaigns in the Rohingya refugee camps"},{"arc":[[42.373161315918,-71.1181182861328],[37.8056831359863,-122.268104553223]],"countries":["United States"],"title":"Quantifying the success of measles vaccination campaigns in the Rohingya refugee camps"},{"arc":[[42.373161315918,-71.1181182861328],[42.373161315918,-71.1181182861328]],"countries":["United States"],"title":"Modeling the Comparative Impact of Individual Quarantine vs. Active Monitoring of Contacts for the Mitigation of COVID-19"},{"arc":[[42.373161315918,-71.1181182861328],[37.2173461914062,-80.4220352172852]],"countries":["United States"],"title":"Modeling the Comparative Impact of Individual Quarantine vs. Active Monitoring of Contacts for the Mitigation of COVID-19"},{"arc":[[49.2629,-123.24671],[37.8056831359863,-122.268104553223]],"countries":["Canada","United States"],"title":"Specific Single or Double Proline Substitutions in the \"Spring-loaded\" Coiled-Coil Region of the Influenza Hemagglutinin Impair or Abolish Membrane Fusion Activity"},{"arc":[[49.2629,-123.24671],[38.0361785888672,-78.5016174316406]],"countries":["Canada","United States"],"title":"Specific Single or Double Proline Substitutions in the \"Spring-loaded\" Coiled-Coil Region of the Influenza Hemagglutinin Impair or Abolish Membrane Fusion Activity"},{"arc":[[37.8056831359863,-122.268104553223],[38.0361785888672,-78.5016174316406]],"countries":["United States"],"title":"Specific Single or Double Proline Substitutions in the \"Spring-loaded\" Coiled-Coil Region of the Influenza Hemagglutinin Impair or Abolish Membrane Fusion Activity"},{"arc":[[51.188419342041,6.79547023773193],[14.477560043335,120.89826965332]],"countries":["Philippines","Germany"],"title":"CEACAM1 induces B-cell survival and is essential for protective antiviral antibody production"},{"arc":[[51.188419342041,6.79547023773193],[52.421459197998,-1.43792998790741]],"countries":["United Kingdom","Germany"],"title":"CEACAM1 induces B-cell survival and is essential for protective antiviral antibody production"},{"arc":[[51.188419342041,6.79547023773193],[51.451831817627,7.01107978820801]],"countries":["Germany"],"title":"CEACAM1 induces B-cell survival and is essential for protective antiviral antibody production"},{"arc":[[51.188419342041,6.79547023773193],[51.4285888671875,6.79955005645752]],"countries":["Germany"],"title":"CEACAM1 induces B-cell survival and is essential for protective antiviral antibody production"},{"arc":[[14.477560043335,120.89826965332],[52.421459197998,-1.43792998790741]],"countries":["United Kingdom","Philippines"],"title":"CEACAM1 induces B-cell survival and is essential for protective antiviral antibody production"},{"arc":[[14.477560043335,120.89826965332],[51.451831817627,7.01107978820801]],"countries":["Philippines","Germany"],"title":"CEACAM1 induces B-cell survival and is essential for protective antiviral antibody production"},{"arc":[[14.477560043335,120.89826965332],[51.4285888671875,6.79955005645752]],"countries":["Philippines","Germany"],"title":"CEACAM1 induces B-cell survival and is essential for protective antiviral antibody production"},{"arc":[[52.421459197998,-1.43792998790741],[51.451831817627,7.01107978820801]],"countries":["United Kingdom","Germany"],"title":"CEACAM1 induces B-cell survival and is essential for protective antiviral antibody production"},{"arc":[[52.421459197998,-1.43792998790741],[51.4285888671875,6.79955005645752]],"countries":["United Kingdom","Germany"],"title":"CEACAM1 induces B-cell survival and is essential for protective antiviral antibody production"},{"arc":[[51.451831817627,7.01107978820801],[51.4285888671875,6.79955005645752]],"countries":["Germany"],"title":"CEACAM1 induces B-cell survival and is essential for protective antiviral antibody production"},{"arc":[[55.908260345459,-3.31926989555359],[51.5002288818359,-0.178939998149872]],"countries":["United Kingdom"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[55.908260345459,-3.31926989555359],[51.5204315185547,-0.130309998989105]],"countries":["United Kingdom"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[55.908260345459,-3.31926989555359],[44.5645294189453,-123.274147033691]],"countries":["United Kingdom","United States"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[55.908260345459,-3.31926989555359],[40.3495407104492,-74.6600875854492]],"countries":["United Kingdom","United States"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[55.908260345459,-3.31926989555359],[52.2025413513184,0.119549997150898]],"countries":["United Kingdom"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[55.908260345459,-3.31926989555359],[42.2762107849121,-83.7407531738281]],"countries":["United States","United Kingdom"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[51.5002288818359,-0.178939998149872],[51.5204315185547,-0.130309998989105]],"countries":["United Kingdom"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[51.5002288818359,-0.178939998149872],[44.5645294189453,-123.274147033691]],"countries":["United Kingdom","United States"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[51.5002288818359,-0.178939998149872],[40.3495407104492,-74.6600875854492]],"countries":["United Kingdom","United States"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[51.5002288818359,-0.178939998149872],[52.2025413513184,0.119549997150898]],"countries":["United Kingdom"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[51.5002288818359,-0.178939998149872],[42.2762107849121,-83.7407531738281]],"countries":["United States","United Kingdom"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[51.5204315185547,-0.130309998989105],[44.5645294189453,-123.274147033691]],"countries":["United Kingdom","United States"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[51.5204315185547,-0.130309998989105],[40.3495407104492,-74.6600875854492]],"countries":["United Kingdom","United States"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[51.5204315185547,-0.130309998989105],[52.2025413513184,0.119549997150898]],"countries":["United Kingdom"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[51.5204315185547,-0.130309998989105],[42.2762107849121,-83.7407531738281]],"countries":["United States","United Kingdom"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[44.5645294189453,-123.274147033691],[40.3495407104492,-74.6600875854492]],"countries":["United States"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[44.5645294189453,-123.274147033691],[52.2025413513184,0.119549997150898]],"countries":["United Kingdom","United States"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[44.5645294189453,-123.274147033691],[42.2762107849121,-83.7407531738281]],"countries":["United States"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[40.3495407104492,-74.6600875854492],[52.2025413513184,0.119549997150898]],"countries":["United Kingdom","United States"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[40.3495407104492,-74.6600875854492],[42.2762107849121,-83.7407531738281]],"countries":["United States"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[52.2025413513184,0.119549997150898],[42.2762107849121,-83.7407531738281]],"countries":["United States","United Kingdom"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[43.383487701416,142.571090698242],[35.6895027160645,138.68879699707]],"countries":["Japan"],"title":"Clinical Medicine Communicating the Risk of Death from Novel Coronavirus Disease (COVID-19)"},{"arc":[[22.333080291748,114.191223144531],[22.333080291748,114.191223144531]],"countries":["Hong Kong SAR"],"title":"Beliefs and Knowledge about Vaccination against AH1N1pdm09 Infection and Uptake Factors among Chinese Parents"},{"arc":[[22.333080291748,114.191223144531],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR"],"title":"Responses to Threat of Influenza A(H7N9) and Support for Live Poultry Markets, Hong Kong, 2013"},{"arc":[[22.2802925109863,114.142951965332],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR"],"title":"Responses to Threat of Influenza A(H7N9) and Support for Live Poultry Markets, Hong Kong, 2013"},{"arc":[[51.5227890014648,-0.136329993605614],[55.947639465332,-3.18207001686096]],"countries":["United Kingdom"],"title":"The role of host genetic factors in respiratory tract infectious diseases: systematic review, meta- analyses and field synopsis"},{"arc":[[51.5227890014648,-0.136329993605614],[55.9452209472656,-3.18803000450134]],"countries":["United Kingdom"],"title":"The role of host genetic factors in respiratory tract infectious diseases: systematic review, meta- analyses and field synopsis"},{"arc":[[55.947639465332,-3.18207001686096],[55.9452209472656,-3.18803000450134]],"countries":["United Kingdom"],"title":"The role of host genetic factors in respiratory tract infectious diseases: systematic review, meta- analyses and field synopsis"},{"arc":[[11.0134401321411,76.9366226196289],[37.8056831359863,-122.268104553223]],"countries":["India","United States"],"title":"Carbon Nanocarriers Deliver siRNA to Intact Plant Cells for Efficient Gene"},{"arc":[[40.9437103271484,40.2619209289551],[30.6250877380371,102.697288513184]],"countries":["Turkey","China"],"title":"Isolation and Selection of Duck Primary Cells as Pathogenic and Innate Immunologic Cell Models for Duck Plague Virus"},{"arc":[[40.9437103271484,40.2619209289551],[44.9734497070312,-93.2378997802734]],"countries":["Turkey","United States"],"title":"Isolation and Selection of Duck Primary Cells as Pathogenic and Innate Immunologic Cell Models for Duck Plague Virus"},{"arc":[[30.6250877380371,102.697288513184],[44.9734497070312,-93.2378997802734]],"countries":["China","United States"],"title":"Isolation and Selection of Duck Primary Cells as Pathogenic and Innate Immunologic Cell Models for Duck Plague Virus"},{"arc":[[28.3938446044922,79.4324493408203],[39.2892150878906,117.349395751953]],"countries":["China","India"],"title":"Structural Basis of Evasion of Cellular Adaptive Immunity by HIV-1 Nef HHS Public Access Author manuscript Online Methods Cloning, E. coli Expression, and Purification"},{"arc":[[28.3938446044922,79.4324493408203],[32.8771514892578,-117.237426757812]],"countries":["India","United States"],"title":"Structural Basis of Evasion of Cellular Adaptive Immunity by HIV-1 Nef HHS Public Access Author manuscript Online Methods Cloning, E. coli Expression, and Purification"},{"arc":[[28.3938446044922,79.4324493408203],[41.3144607543945,-72.9232711791992]],"countries":["India","United States"],"title":"Structural Basis of Evasion of Cellular Adaptive Immunity by HIV-1 Nef HHS Public Access Author manuscript Online Methods Cloning, E. coli Expression, and Purification"},{"arc":[[39.2892150878906,117.349395751953],[32.8771514892578,-117.237426757812]],"countries":["China","United States"],"title":"Structural Basis of Evasion of Cellular Adaptive Immunity by HIV-1 Nef HHS Public Access Author manuscript Online Methods Cloning, E. coli Expression, and Purification"},{"arc":[[39.2892150878906,117.349395751953],[41.3144607543945,-72.9232711791992]],"countries":["China","United States"],"title":"Structural Basis of Evasion of Cellular Adaptive Immunity by HIV-1 Nef HHS Public Access Author manuscript Online Methods Cloning, E. coli Expression, and Purification"},{"arc":[[32.8771514892578,-117.237426757812],[41.3144607543945,-72.9232711791992]],"countries":["United States"],"title":"Structural Basis of Evasion of Cellular Adaptive Immunity by HIV-1 Nef HHS Public Access Author manuscript Online Methods Cloning, E. coli Expression, and Purification"},{"arc":[[51.5002288818359,-0.178939998149872],[51.5002288818359,-0.178939998149872]],"countries":["United Kingdom"],"title":"Supplementary Text: The spatial resolution of epidemic peaks"},{"arc":[[51.5002288818359,-0.178939998149872],[39.1860809326172,-96.5832672119141]],"countries":["United Kingdom","United States"],"title":"NAR Breakthrough Article A novel role for poly(C) binding proteins in programmed ribosomal frameshifting"},{"arc":[[51.5002288818359,-0.178939998149872],[52.1658325195312,4.47749996185303]],"countries":["United Kingdom","Netherlands"],"title":"NAR Breakthrough Article A novel role for poly(C) binding proteins in programmed ribosomal frameshifting"},{"arc":[[51.5002288818359,-0.178939998149872],[52.2025413513184,0.119549997150898]],"countries":["United Kingdom"],"title":"NAR Breakthrough Article A novel role for poly(C) binding proteins in programmed ribosomal frameshifting"},{"arc":[[39.1860809326172,-96.5832672119141],[52.1658325195312,4.47749996185303]],"countries":["United States","Netherlands"],"title":"NAR Breakthrough Article A novel role for poly(C) binding proteins in programmed ribosomal frameshifting"},{"arc":[[39.1860809326172,-96.5832672119141],[52.2025413513184,0.119549997150898]],"countries":["United Kingdom","United States"],"title":"NAR Breakthrough Article A novel role for poly(C) binding proteins in programmed ribosomal frameshifting"},{"arc":[[52.1658325195312,4.47749996185303],[52.2025413513184,0.119549997150898]],"countries":["United Kingdom","Netherlands"],"title":"NAR Breakthrough Article A novel role for poly(C) binding proteins in programmed ribosomal frameshifting"},{"arc":[[22.9680194854736,88.5302581787109],[22.9680194854736,88.5302581787109]],"countries":["India"],"title":"Mouse Hepatitis Virus Infection Upregulates Genes Involved in Innate Immune Responses"},{"arc":[[22.9680194854736,88.5302581787109],[39.9484710693359,-75.1576614379883]],"countries":["India","United States"],"title":"Mouse Hepatitis Virus Infection Upregulates Genes Involved in Innate Immune Responses"},{"arc":[[22.9680194854736,88.5302581787109],[40.0039215087891,-105.26683807373]],"countries":["India","United States"],"title":"Mouse Hepatitis Virus Infection Upregulates Genes Involved in Innate Immune Responses"},{"arc":[[22.9680194854736,88.5302581787109],[39.9530487060547,-75.1940231323242]],"countries":["United States","India"],"title":"Mouse Hepatitis Virus Infection Upregulates Genes Involved in Innate Immune Responses"},{"arc":[[39.9484710693359,-75.1576614379883],[40.0039215087891,-105.26683807373]],"countries":["United States"],"title":"Mouse Hepatitis Virus Infection Upregulates Genes Involved in Innate Immune Responses"},{"arc":[[39.9484710693359,-75.1576614379883],[39.9530487060547,-75.1940231323242]],"countries":["United States"],"title":"Mouse Hepatitis Virus Infection Upregulates Genes Involved in Innate Immune Responses"},{"arc":[[40.0039215087891,-105.26683807373],[39.9530487060547,-75.1940231323242]],"countries":["United States"],"title":"Mouse Hepatitis Virus Infection Upregulates Genes Involved in Innate Immune Responses"},{"arc":[[22.4931182861328,79.7270126342773],[51.1218070983887,10.4006948471069]],"countries":["Germany","India"],"title":"viruses Reverse Genetic Approaches for the Generation of Recombinant Zika Virus"},{"arc":[[22.4931182861328,79.7270126342773],[43.1265411376953,-77.6315383911133]],"countries":["India","United States"],"title":"viruses Reverse Genetic Approaches for the Generation of Recombinant Zika Virus"},{"arc":[[51.1218070983887,10.4006948471069],[43.1265411376953,-77.6315383911133]],"countries":["Germany","United States"],"title":"viruses Reverse Genetic Approaches for the Generation of Recombinant Zika Virus"},{"arc":[[40.7182693481445,46.4133987426758],[38.9907493591309,48.5817184448242]],"countries":["Azerbaijan"],"title":"Supplementary Information Mechanisms for lyssavirus persistence in non-synanthropic bats in Europe: insights from a modeling study"},{"arc":[[40.7182693481445,46.4133987426758],[30.7602596282959,47.6596298217773]],"countries":["Azerbaijan","Iraq"],"title":"Supplementary Information Mechanisms for lyssavirus persistence in non-synanthropic bats in Europe: insights from a modeling study"},{"arc":[[40.7182693481445,46.4133987426758],[41.3872909545898,2.16295003890991]],"countries":["Azerbaijan","Spain"],"title":"Supplementary Information Mechanisms for lyssavirus persistence in non-synanthropic bats in Europe: insights from a modeling study"},{"arc":[[38.9907493591309,48.5817184448242],[30.7602596282959,47.6596298217773]],"countries":["Iraq","Azerbaijan"],"title":"Supplementary Information Mechanisms for lyssavirus persistence in non-synanthropic bats in Europe: insights from a modeling study"},{"arc":[[38.9907493591309,48.5817184448242],[41.3872909545898,2.16295003890991]],"countries":["Azerbaijan","Spain"],"title":"Supplementary Information Mechanisms for lyssavirus persistence in non-synanthropic bats in Europe: insights from a modeling study"},{"arc":[[30.7602596282959,47.6596298217773],[41.3872909545898,2.16295003890991]],"countries":["Iraq","Spain"],"title":"Supplementary Information Mechanisms for lyssavirus persistence in non-synanthropic bats in Europe: insights from a modeling study"},{"arc":[[51.1218070983887,10.4006948471069],[40.7182693481445,46.4133987426758]],"countries":["Azerbaijan","Germany"],"title":"OJPHI Early-warning health and process indicators for sentinel surveillance in Early-warning health and process indicators for sentinel surveillance in Madagascar 2007-2011"},{"arc":[[51.1218070983887,10.4006948471069],[-19.3828773498535,46.6958503723145]],"countries":["Germany","Madagascar"],"title":"OJPHI Early-warning health and process indicators for sentinel surveillance in Early-warning health and process indicators for sentinel surveillance in Madagascar 2007-2011"},{"arc":[[51.1218070983887,10.4006948471069],[46.2638092041016,2.3486499786377]],"countries":["Germany","France"],"title":"OJPHI Early-warning health and process indicators for sentinel surveillance in Early-warning health and process indicators for sentinel surveillance in Madagascar 2007-2011"},{"arc":[[40.7182693481445,46.4133987426758],[40.7182693481445,46.4133987426758]],"countries":["Azerbaijan"],"title":"OJPHI Early-warning health and process indicators for sentinel surveillance in Early-warning health and process indicators for sentinel surveillance in Madagascar 2007-2011"},{"arc":[[40.7182693481445,46.4133987426758],[-19.3828773498535,46.6958503723145]],"countries":["Azerbaijan","Madagascar"],"title":"OJPHI Early-warning health and process indicators for sentinel surveillance in Early-warning health and process indicators for sentinel surveillance in Madagascar 2007-2011"},{"arc":[[40.7182693481445,46.4133987426758],[46.2638092041016,2.3486499786377]],"countries":["Azerbaijan","France"],"title":"OJPHI Early-warning health and process indicators for sentinel surveillance in Early-warning health and process indicators for sentinel surveillance in Madagascar 2007-2011"},{"arc":[[-19.3828773498535,46.6958503723145],[46.2638092041016,2.3486499786377]],"countries":["France","Madagascar"],"title":"OJPHI Early-warning health and process indicators for sentinel surveillance in Early-warning health and process indicators for sentinel surveillance in Madagascar 2007-2011"},{"arc":[[51.1218070983887,10.4006948471069],[51.1218070983887,10.4006948471069]],"countries":["Germany"],"title":"Genomic Analyses of Human European Diversity at the Southwestern Edge: Isolation, African Influence and Disease Associations in the Canary Islands"},{"arc":[[51.1218070983887,10.4006948471069],[28.4607791900635,-16.2639007568359]],"countries":["Germany","Spain"],"title":"Genomic Analyses of Human European Diversity at the Southwestern Edge: Isolation, African Influence and Disease Associations in the Canary Islands"},{"arc":[[42.0247383117676,-93.6445465087891],[38.5367012023926,-121.749008178711]],"countries":["United States"],"title":"Randomized controlled clinical trial on the effect of oral immunoglobulin supplementation on neonatal dairy calves with diarrhea"},{"arc":[[44.5259094238281,11.0393409729004],[44.9734497070312,-93.2378997802734]],"countries":["Italy","United States"],"title":"Porcine Epidemic Diarrhea Virus and Discovery of a Recombinant Swine Enteric Coronavirus, Italy Emerging Infectious Diseases Journal Podcasts"},{"arc":[[44.5259094238281,11.0393409729004],[44.5259094238281,11.0393409729004]],"countries":["Italy"],"title":"Porcine Epidemic Diarrhea Virus and Discovery of a Recombinant Swine Enteric Coronavirus, Italy Emerging Infectious Diseases Journal Podcasts"},{"arc":[[44.9734497070312,-93.2378997802734],[44.5259094238281,11.0393409729004]],"countries":["Italy","United States"],"title":"Porcine Epidemic Diarrhea Virus and Discovery of a Recombinant Swine Enteric Coronavirus, Italy Emerging Infectious Diseases Journal Podcasts"},{"arc":[[-19.3288898468018,146.76057434082],[-27.4452590942383,153.009536743164]],"countries":["Australia"],"title":"Public Health Responses to and Challenges for the Control of Dengue Transmission in High-Income Countries: Four Case Studies"},{"arc":[[-19.3288898468018,146.76057434082],[-35.2755393981934,149.121124267578]],"countries":["Australia"],"title":"Public Health Responses to and Challenges for the Control of Dengue Transmission in High-Income Countries: Four Case Studies"},{"arc":[[-19.3288898468018,146.76057434082],[-34.9172286987305,138.60710144043]],"countries":["Australia"],"title":"Public Health Responses to and Challenges for the Control of Dengue Transmission in High-Income Countries: Four Case Studies"},{"arc":[[-27.4452590942383,153.009536743164],[-35.2755393981934,149.121124267578]],"countries":["Australia"],"title":"Public Health Responses to and Challenges for the Control of Dengue Transmission in High-Income Countries: Four Case Studies"},{"arc":[[-27.4452590942383,153.009536743164],[-34.9172286987305,138.60710144043]],"countries":["Australia"],"title":"Public Health Responses to and Challenges for the Control of Dengue Transmission in High-Income Countries: Four Case Studies"},{"arc":[[-35.2755393981934,149.121124267578],[-34.9172286987305,138.60710144043]],"countries":["Australia"],"title":"Public Health Responses to and Challenges for the Control of Dengue Transmission in High-Income Countries: Four Case Studies"},{"arc":[[31.0254402160645,121.436302185059],[31.0254402160645,121.436302185059]],"countries":["China"],"title":"EXPERIMENTAL AND THERAPEUTIC MEDICINE Dimethyloxaloylglycine increases bone repair capacity of adipose-derived stem cells in the treatment of osteonecrosis of the femoral head"},{"arc":[[23.1312255859375,113.347915649414],[14.3596153259277,-14.4684610366821]],"countries":["Senegal","China"],"title":"Breaking down of healthcare system: Mathematical modelling for controlling the novel coronavirus (2019-nCoV) outbreak in Wuhan, China"},{"arc":[[23.1312255859375,113.347915649414],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR","China"],"title":"Breaking down of healthcare system: Mathematical modelling for controlling the novel coronavirus (2019-nCoV) outbreak in Wuhan, China"},{"arc":[[14.3596153259277,-14.4684610366821],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR","Senegal"],"title":"Breaking down of healthcare system: Mathematical modelling for controlling the novel coronavirus (2019-nCoV) outbreak in Wuhan, China"},{"arc":[[39.2973403930664,-76.6152191162109],[38.5466918945312,-121.744567871094]],"countries":["United States"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[39.2973403930664,-76.6152191162109],[38.2007598876953,-122.447616577148]],"countries":["United States"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[39.2973403930664,-76.6152191162109],[45.5065994262695,-73.5779571533203]],"countries":["United States","Canada"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[39.2973403930664,-76.6152191162109],[6.48379993438721,2.35245990753174]],"countries":["United States","Benin"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[39.2973403930664,-76.6152191162109],[47.3191909790039,5.06463003158569]],"countries":["United States","France"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[39.2973403930664,-76.6152191162109],[-19.0004577636719,29.8718376159668]],"countries":["United States","Zimbabwe"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[38.5466918945312,-121.744567871094],[38.2007598876953,-122.447616577148]],"countries":["United States"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[38.5466918945312,-121.744567871094],[45.5065994262695,-73.5779571533203]],"countries":["United States","Canada"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[38.5466918945312,-121.744567871094],[6.48379993438721,2.35245990753174]],"countries":["United States","Benin"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[38.5466918945312,-121.744567871094],[47.3191909790039,5.06463003158569]],"countries":["United States","France"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[38.5466918945312,-121.744567871094],[-19.0004577636719,29.8718376159668]],"countries":["United States","Zimbabwe"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[38.2007598876953,-122.447616577148],[45.5065994262695,-73.5779571533203]],"countries":["United States","Canada"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[38.2007598876953,-122.447616577148],[6.48379993438721,2.35245990753174]],"countries":["United States","Benin"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[38.2007598876953,-122.447616577148],[47.3191909790039,5.06463003158569]],"countries":["United States","France"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[38.2007598876953,-122.447616577148],[-19.0004577636719,29.8718376159668]],"countries":["United States","Zimbabwe"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[45.5065994262695,-73.5779571533203],[6.48379993438721,2.35245990753174]],"countries":["Canada","Benin"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[45.5065994262695,-73.5779571533203],[47.3191909790039,5.06463003158569]],"countries":["Canada","France"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[45.5065994262695,-73.5779571533203],[-19.0004577636719,29.8718376159668]],"countries":["Canada","Zimbabwe"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[6.48379993438721,2.35245990753174],[47.3191909790039,5.06463003158569]],"countries":["France","Benin"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[6.48379993438721,2.35245990753174],[-19.0004577636719,29.8718376159668]],"countries":["Benin","Zimbabwe"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[47.3191909790039,5.06463003158569],[47.3191909790039,5.06463003158569]],"countries":["France"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[47.3191909790039,5.06463003158569],[-19.0004577636719,29.8718376159668]],"countries":["France","Zimbabwe"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[50.5807495117188,8.67675018310547],[50.5807495117188,8.67675018310547]],"countries":["Germany"],"title":"Reverse Genetics for Type I Feline Coronavirus Field Isolate To Study the Molecular Pathogenesis of Feline Infectious Peritonitis"},{"arc":[[39.1860809326172,-96.5832672119141],[32.0583801269531,118.79647064209]],"countries":["China","United States"],"title":"Time-varying transmission dynamics of Novel Coronavirus Pneumonia in China At a Glance Commentary Scientific Knowledge on the Subject: Since"},{"arc":[[39.1860809326172,-96.5832672119141],[40.0059814453125,116.326812744141]],"countries":["United States","China"],"title":"Time-varying transmission dynamics of Novel Coronavirus Pneumonia in China At a Glance Commentary Scientific Knowledge on the Subject: Since"},{"arc":[[32.0583801269531,118.79647064209],[40.0059814453125,116.326812744141]],"countries":["China"],"title":"Time-varying transmission dynamics of Novel Coronavirus Pneumonia in China At a Glance Commentary Scientific Knowledge on the Subject: Since"},{"arc":[[34.0223503112793,-118.291114807129],[50.3743896484375,-4.13887977600098]],"countries":["United States","United Kingdom"],"title":"International Journal of Health Geographics Musings on privacy issues in health research involving disaggregate geographic data about individuals"},{"arc":[[55.8003005981445,49.108268737793],[55.8003005981445,49.108268737793]],"countries":["Russia"],"title":"Article 747 ORIGINAL RESEARCH"},{"arc":[[21.667760848999,39.1527290344238],[24.7343902587891,46.6319313049316]],"countries":["Saudi Arabia"],"title":"Respiratory Tract Viral Infections and Coinfections Identified by AnyplexC II RV16 Detection Kit in Pediatric Patients at a Riyadh Tertiary Care Hospital"},{"arc":[[24.7343902587891,46.6319313049316],[24.7343902587891,46.6319313049316]],"countries":["Saudi Arabia"],"title":"Article 9 Alangari AA (2020) Multiple Family Members With Delayed Cord Separtion and Combined Immunodeficiency With Novel Mutation in IKBKB"},{"arc":[[24.7343902587891,46.6319313049316],[40.9437103271484,40.2619209289551]],"countries":["Turkey","Saudi Arabia"],"title":"Article 9 Alangari AA (2020) Multiple Family Members With Delayed Cord Separtion and Combined Immunodeficiency With Novel Mutation in IKBKB"},{"arc":[[24.7343902587891,46.6319313049316],[40.8453598022461,14.2576427459717]],"countries":["Saudi Arabia","Italy"],"title":"Article 9 Alangari AA (2020) Multiple Family Members With Delayed Cord Separtion and Combined Immunodeficiency With Novel Mutation in IKBKB"},{"arc":[[40.9437103271484,40.2619209289551],[40.8453598022461,14.2576427459717]],"countries":["Turkey","Italy"],"title":"Article 9 Alangari AA (2020) Multiple Family Members With Delayed Cord Separtion and Combined Immunodeficiency With Novel Mutation in IKBKB"},{"arc":[[42.9547386169434,-78.8192367553711],[36.611458,127.325192]],"countries":["United States","South Korea"],"title":"Selection and Characterization of Monoclonal Antibodies Targeting Middle East Respiratory Syndrome Coronavirus through a Human Synthetic Fab Phage Display Library Panning"},{"arc":[[50.877628326416,4.70719003677368],[50.877628326416,4.70719003677368]],"countries":["Belgium"],"title":"Modular approach to customise sample preparation procedures for viral metagenomics: a reproducible protocol for virome analysis"},{"arc":[[50.877628326416,4.70719003677368],[53.9120407104492,15.1994600296021]],"countries":["Belgium","Poland"],"title":"Modular approach to customise sample preparation procedures for viral metagenomics: a reproducible protocol for virome analysis"},{"arc":[[53.9120407104492,15.1994600296021],[50.877628326416,4.70719003677368]],"countries":["Belgium","Poland"],"title":"Modular approach to customise sample preparation procedures for viral metagenomics: a reproducible protocol for virome analysis"},{"arc":[[35.015510559082,135.770034790039],[21.1394691467285,79.0602798461914]],"countries":["India","Japan"],"title":"BMC Structural Biology A model of tripeptidyl-peptidase I (CLN2), a ubiquitous and highly conserved member of the sedolisin family of serine-carboxyl peptidases"},{"arc":[[35.015510559082,135.770034790039],[29.649730682373,-82.3411331176758]],"countries":["Japan","United States"],"title":"BMC Structural Biology A model of tripeptidyl-peptidase I (CLN2), a ubiquitous and highly conserved member of the sedolisin family of serine-carboxyl peptidases"},{"arc":[[21.1394691467285,79.0602798461914],[21.1394691467285,79.0602798461914]],"countries":["India"],"title":"BMC Structural Biology A model of tripeptidyl-peptidase I (CLN2), a ubiquitous and highly conserved member of the sedolisin family of serine-carboxyl peptidases"},{"arc":[[21.1394691467285,79.0602798461914],[29.649730682373,-82.3411331176758]],"countries":["India","United States"],"title":"BMC Structural Biology A model of tripeptidyl-peptidase I (CLN2), a ubiquitous and highly conserved member of the sedolisin family of serine-carboxyl peptidases"},{"arc":[[54.0102615356445,-2.78708004951477],[51.4570693969727,-2.60121011734009]],"countries":["United Kingdom"],"title":"6 NIHR Health Protection Research Unit in Gastrointestinal Infections"},{"arc":[[54.0102615356445,-2.78708004951477],[53.403148651123,-2.96319007873535]],"countries":["United Kingdom"],"title":"6 NIHR Health Protection Research Unit in Gastrointestinal Infections"},{"arc":[[51.4570693969727,-2.60121011734009],[53.403148651123,-2.96319007873535]],"countries":["United Kingdom"],"title":"6 NIHR Health Protection Research Unit in Gastrointestinal Infections"},{"arc":[[52.1658325195312,4.47749996185303],[48.2128105163574,16.3610992431641]],"countries":["Austria","Netherlands"],"title":"Irreversible inactivation of ISG15 by a viral leader protease enables alternative infection detection strategies"},{"arc":[[52.1658325195312,4.47749996185303],[51.300220489502,-0.645680010318756]],"countries":["Netherlands","United Kingdom"],"title":"Irreversible inactivation of ISG15 by a viral leader protease enables alternative infection detection strategies"},{"arc":[[52.1658325195312,4.47749996185303],[52.08896,5.1784]],"countries":["Netherlands"],"title":"Irreversible inactivation of ISG15 by a viral leader protease enables alternative infection detection strategies"},{"arc":[[48.2128105163574,16.3610992431641],[51.300220489502,-0.645680010318756]],"countries":["Austria","United Kingdom"],"title":"Irreversible inactivation of ISG15 by a viral leader protease enables alternative infection detection strategies"},{"arc":[[48.2128105163574,16.3610992431641],[52.08896,5.1784]],"countries":["Austria","Netherlands"],"title":"Irreversible inactivation of ISG15 by a viral leader protease enables alternative infection detection strategies"},{"arc":[[51.300220489502,-0.645680010318756],[52.08896,5.1784]],"countries":["United Kingdom","Netherlands"],"title":"Irreversible inactivation of ISG15 by a viral leader protease enables alternative infection detection strategies"},{"arc":[[30.4157905578613,-91.1773529052734],[-27.4977779388428,153.012771606445]],"countries":["Australia","United States"],"title":"Type 1 Interferons and NK Cells Limit Murine Cytomegalovirus Escape from the Lymph Node Subcapsular Sinus"},{"arc":[[-21.1429405212402,149.183715820312],[23.7489929199219,120.971282958984]],"countries":["Taiwan","Australia"],"title":"BMC Medical Genetics Association of HLA class I with severe acute respiratory syndrome coronavirus infection"},{"arc":[[-21.1429405212402,149.183715820312],[25.0373706817627,121.563552856445]],"countries":["Australia","Taiwan"],"title":"BMC Medical Genetics Association of HLA class I with severe acute respiratory syndrome coronavirus infection"},{"arc":[[23.7489929199219,120.971282958984],[25.0373706817627,121.563552856445]],"countries":["Taiwan"],"title":"BMC Medical Genetics Association of HLA class I with severe acute respiratory syndrome coronavirus infection"},{"arc":[[44.6669807434082,-90.1736297607422],[51.5086784362793,-0.143889993429184]],"countries":["United States","United Kingdom"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[44.6669807434082,-90.1736297607422],[33.4540901184082,-88.7920227050781]],"countries":["United States"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[44.6669807434082,-90.1736297607422],[49.9682197570801,6.49822998046875]],"countries":["United States","Germany"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[44.6669807434082,-90.1736297607422],[30.6127891540527,-96.339599609375]],"countries":["United States"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[44.6669807434082,-90.1736297607422],[37.7633209228516,-122.458541870117]],"countries":["United States"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[44.6669807434082,-90.1736297607422],[29.649730682373,-82.3411331176758]],"countries":["United States"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[51.5086784362793,-0.143889993429184],[33.4540901184082,-88.7920227050781]],"countries":["United Kingdom","United States"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[51.5086784362793,-0.143889993429184],[49.9682197570801,6.49822998046875]],"countries":["United Kingdom","Germany"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[51.5086784362793,-0.143889993429184],[30.6127891540527,-96.339599609375]],"countries":["United Kingdom","United States"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[51.5086784362793,-0.143889993429184],[37.7633209228516,-122.458541870117]],"countries":["United Kingdom","United States"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[51.5086784362793,-0.143889993429184],[29.649730682373,-82.3411331176758]],"countries":["United Kingdom","United States"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[33.4540901184082,-88.7920227050781],[49.9682197570801,6.49822998046875]],"countries":["United States","Germany"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[33.4540901184082,-88.7920227050781],[30.6127891540527,-96.339599609375]],"countries":["United States"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[33.4540901184082,-88.7920227050781],[37.7633209228516,-122.458541870117]],"countries":["United States"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[33.4540901184082,-88.7920227050781],[29.649730682373,-82.3411331176758]],"countries":["United States"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[49.9682197570801,6.49822998046875],[30.6127891540527,-96.339599609375]],"countries":["Germany","United States"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[49.9682197570801,6.49822998046875],[37.7633209228516,-122.458541870117]],"countries":["Germany","United States"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[49.9682197570801,6.49822998046875],[29.649730682373,-82.3411331176758]],"countries":["Germany","United States"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[30.6127891540527,-96.339599609375],[37.7633209228516,-122.458541870117]],"countries":["United States"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[30.6127891540527,-96.339599609375],[29.649730682373,-82.3411331176758]],"countries":["United States"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[37.7633209228516,-122.458541870117],[29.649730682373,-82.3411331176758]],"countries":["United States"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[38.3835906982422,-81.7656936645508],[39.9530487060547,-75.1940231323242]],"countries":["United States"],"title":"Chaperone-Mediated Autophagy Protein BAG3 Negatively Regulates Ebola and Marburg VP40-Mediated Egress"},{"arc":[[38.3835906982422,-81.7656936645508],[30.2787208557129,-97.7324523925781]],"countries":["United States"],"title":"Chaperone-Mediated Autophagy Protein BAG3 Negatively Regulates Ebola and Marburg VP40-Mediated Egress"},{"arc":[[38.3835906982422,-81.7656936645508],[43.6486892700195,-79.3854370117188]],"countries":["United States","Canada"],"title":"Chaperone-Mediated Autophagy Protein BAG3 Negatively Regulates Ebola and Marburg VP40-Mediated Egress"},{"arc":[[39.9530487060547,-75.1940231323242],[30.2787208557129,-97.7324523925781]],"countries":["United States"],"title":"Chaperone-Mediated Autophagy Protein BAG3 Negatively Regulates Ebola and Marburg VP40-Mediated Egress"},{"arc":[[39.9530487060547,-75.1940231323242],[43.6486892700195,-79.3854370117188]],"countries":["United States","Canada"],"title":"Chaperone-Mediated Autophagy Protein BAG3 Negatively Regulates Ebola and Marburg VP40-Mediated Egress"},{"arc":[[30.2787208557129,-97.7324523925781],[43.6486892700195,-79.3854370117188]],"countries":["Canada","United States"],"title":"Chaperone-Mediated Autophagy Protein BAG3 Negatively Regulates Ebola and Marburg VP40-Mediated Egress"},{"arc":[[42.7294616699219,-84.4804077148438],[40.0039215087891,-105.26683807373]],"countries":["United States"],"title":"Saturation mutagenesis genome engineering of infective X174 bacteriophage via unamplified oligo pools and golden gate assembly"},{"arc":[[42.7294616699219,-84.4804077148438],[46.7281913757324,-117.006896972656]],"countries":["United States"],"title":"Saturation mutagenesis genome engineering of infective X174 bacteriophage via unamplified oligo pools and golden gate assembly"},{"arc":[[40.0039215087891,-105.26683807373],[46.7281913757324,-117.006896972656]],"countries":["United States"],"title":"Saturation mutagenesis genome engineering of infective X174 bacteriophage via unamplified oligo pools and golden gate assembly"},{"arc":[[40.9437103271484,40.2619209289551],[32.5642623901367,54.3036727905273]],"countries":["Turkey","Iran"],"title":"Preparation and Evaluation of Ribonuclease-Resistant Viral HIV RNA Standards Based on Armored RNA Technology"},{"arc":[[40.9437103271484,40.2619209289551],[35.6887702941895,51.4150314331055]],"countries":["Turkey","Iran"],"title":"Preparation and Evaluation of Ribonuclease-Resistant Viral HIV RNA Standards Based on Armored RNA Technology"},{"arc":[[32.5642623901367,54.3036727905273],[35.6887702941895,51.4150314331055]],"countries":["Iran"],"title":"Preparation and Evaluation of Ribonuclease-Resistant Viral HIV RNA Standards Based on Armored RNA Technology"},{"arc":[[35.6887702941895,51.4150314331055],[35.6887702941895,51.4150314331055]],"countries":["Iran"],"title":"Preparation and Evaluation of Ribonuclease-Resistant Viral HIV RNA Standards Based on Armored RNA Technology"},{"arc":[[40.7900657653809,-73.9532470703125],[43.6486892700195,-79.3854370117188]],"countries":["United States","Canada"],"title":"Patient Contact Recall after SARS Exposure"},{"arc":[[32.0583801269531,118.79647064209],[33.9571990966797,-83.3740615844727]],"countries":["United States","China"],"title":"Identification of Nuclear Localization Signals in the ORF2 Protein of Porcine Circovirus Type 3"},{"arc":[[32.0583801269531,118.79647064209],[32.3935813903809,119.412689208984]],"countries":["China"],"title":"Identification of Nuclear Localization Signals in the ORF2 Protein of Porcine Circovirus Type 3"},{"arc":[[33.9571990966797,-83.3740615844727],[32.3935813903809,119.412689208984]],"countries":["United States","China"],"title":"Identification of Nuclear Localization Signals in the ORF2 Protein of Porcine Circovirus Type 3"},{"arc":[[39.1381492614746,117.150108337402],[14.165060043335,121.215789794922]],"countries":["China","Philippines"],"title":"DNA segment of African Swine Fever Virus 1 first detected in hard ticks from sheep and bovine"},{"arc":[[21.1394691467285,79.0602798461914],[-69.1330032348633,-63.6669998168945]],"countries":["Argentina","India"],"title":"mTOR inhibitors lower an intrinsic barrier to virus infection mediated by IFITM3"},{"arc":[[30.3002605438232,108.037666320801],[23.7489929199219,120.971282958984]],"countries":["Taiwan","China"],"title":"The Infection of Chicken Tracheal Epithelial Cells with a H6N1 Avian Influenza Virus"},{"arc":[[45.3010215759277,8.85933017730713],[37.9732398986816,15.6630697250366]],"countries":["Italy"],"title":"Interferon-a Improves Phosphoantigen-Induced Vc9Vd2 T-Cells Interferon-c Production during Chronic HCV Infection"},{"arc":[[40.9437103271484,40.2619209289551],[-69.1330032348633,-63.6669998168945]],"countries":["Turkey","Argentina"],"title":"Supplementary Information Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis"},{"arc":[[40.9437103271484,40.2619209289551],[35.4666900634766,139.621841430664]],"countries":["Turkey","Japan"],"title":"Analysis of VSV pseudotype virus infection mediated by rubella virus envelope proteins OPEN"},{"arc":[[39.0048141479492,-77.0975341796875],[39.0048141479492,-77.0975341796875]],"countries":["United States"],"title":"Lactate Dehydrogenase-Elevating Virus Induces Systemic Lymphocyte Activation via TLR7-Dependent IFNa Responses by Plasmacytoid Dendritic Cells"},{"arc":[[39.0048141479492,-77.0975341796875],[39.0048141479492,-77.0975341796875]],"countries":["United States"],"title":"Pulmonary Histoplasma Infection After Allogeneic Hematopoietic Stem Cell Transplantation: Case Report and Review of the Literature"},{"arc":[[23.7489929199219,120.971282958984],[25.0119304656982,121.465621948242]],"countries":["Taiwan"],"title":"Are children less susceptible to COVID-19?"},{"arc":[[23.7489929199219,120.971282958984],[24.1632404327393,120.648208618164]],"countries":["Taiwan"],"title":"Are children less susceptible to COVID-19?"},{"arc":[[25.0119304656982,121.465621948242],[24.1632404327393,120.648208618164]],"countries":["Taiwan"],"title":"Are children less susceptible to COVID-19?"},{"arc":[[1.29718005657196,103.77774810791],[1.32175004482269,103.846237182617]],"countries":["Singapore"],"title":"How HIV patients construct liveable identities in a shame based culture: the case of Singapore"},{"arc":[[55.1693992614746,-114.511054992676],[-69.1330032348633,-63.6669998168945]],"countries":["Canada","Argentina"],"title":"Supplemental Information Bioengineering and Semisynthesis of an Optimized Cyclophilin Inhibitor for Treatment of Chronic Viral Infection"},{"arc":[[55.1693992614746,-114.511054992676],[50.877628326416,4.70719003677368]],"countries":["Canada","Belgium"],"title":"Supplemental Information Bioengineering and Semisynthesis of an Optimized Cyclophilin Inhibitor for Treatment of Chronic Viral Infection"},{"arc":[[-69.1330032348633,-63.6669998168945],[50.877628326416,4.70719003677368]],"countries":["Argentina","Belgium"],"title":"Supplemental Information Bioengineering and Semisynthesis of an Optimized Cyclophilin Inhibitor for Treatment of Chronic Viral Infection"},{"arc":[[36.6533355712891,137.981689453125],[37.8056831359863,-122.268104553223]],"countries":["Japan","United States"],"title":"Epidemiological evaluation of cat health at a first-response animal shelter in Fukushima, following the Great East Japan Earthquakes of 2011"},{"arc":[[42.0617485046387,-87.6770706176758],[41.8953018188477,-87.6160507202148]],"countries":["United States"],"title":"Novel Variants of Angiotensin Converting Enzyme-2 of Shorter Molecular Size to Target the Kidney Renin Angiotensin System"},{"arc":[[40.0063018798828,-83.0163803100586],[40.807071685791,-77.8588790893555]],"countries":["United States"],"title":"To Go or Stay: The Development, Benefit, and Detriment of Tissue-Resident Memory CD8 T Cells during Central Nervous System Viral Infections"},{"arc":[[51.7589988708496,-1.26400005817413],[-37.7035598754883,145.180358886719]],"countries":["Australia","United Kingdom"],"title":"An early report from newly established laboratory- based influenza surveillance in Lao PDR"},{"arc":[[39.9925537109375,116.310485839844],[42.2762107849121,-83.7407531738281]],"countries":["China","United States"],"title":"Is Generalized Maternal Optimism or Pessimism During Pregnancy Associated with Unplanned Cesarean Section Deliveries in China?"},{"arc":[[39.9925537109375,116.310485839844],[35.9053153991699,-79.0477142333984]],"countries":["China","United States"],"title":"Is Generalized Maternal Optimism or Pessimism During Pregnancy Associated with Unplanned Cesarean Section Deliveries in China?"},{"arc":[[42.2762107849121,-83.7407531738281],[35.9053153991699,-79.0477142333984]],"countries":["United States"],"title":"Is Generalized Maternal Optimism or Pessimism During Pregnancy Associated with Unplanned Cesarean Section Deliveries in China?"},{"arc":[[40.3495407104492,-74.6600875854492],[51.1218070983887,10.4006948471069]],"countries":["Germany","United States"],"title":"Long-term trends in seasonality of mortality in urban Madagascar: the role of the epidemiological transition"},{"arc":[[36.2617607116699,50.0107688903809],[36.2617607116699,50.0107688903809]],"countries":["Iran"],"title":"Obvious and Hidden Anxiety and the Related Factors in Operating Room Nurses Employed in General Hospital, Qazvin, Iran: A Cross-Sectional Study"},{"arc":[[8.59595775604248,29.9919891357422],[49.4165115356445,8.67146015167236]],"countries":["Germany","South Sudan"],"title":"Nosocomial Epidemiology in Patients with Hematological Disorders"},{"arc":[[8.59595775604248,29.9919891357422],[49.787841796875,9.93556022644043]],"countries":["South Sudan","Germany"],"title":"Nosocomial Epidemiology in Patients with Hematological Disorders"},{"arc":[[49.4165115356445,8.67146015167236],[49.787841796875,9.93556022644043]],"countries":["Germany"],"title":"Nosocomial Epidemiology in Patients with Hematological Disorders"},{"arc":[[40.9437103271484,40.2619209289551],[37.8056831359863,-122.268104553223]],"countries":["Turkey","United States"],"title":"Polyadenylation of genomic RNA and initiation of antigenomic RNA in a positive-strand RNA virus are controlled by the same cis-element"},{"arc":[[40.9437103271484,40.2619209289551],[52.08896,5.1784]],"countries":["Turkey","Netherlands"],"title":"Polyadenylation of genomic RNA and initiation of antigenomic RNA in a positive-strand RNA virus are controlled by the same cis-element"},{"arc":[[37.8056831359863,-122.268104553223],[52.08896,5.1784]],"countries":["United States","Netherlands"],"title":"Polyadenylation of genomic RNA and initiation of antigenomic RNA in a positive-strand RNA virus are controlled by the same cis-element"},{"arc":[[42.8768310546875,-8.54432010650635],[52.38591,-1.55807]],"countries":["Spain","United Kingdom"],"title":"Bacteremia in Children Hospitalized with Respiratory Syncytial Virus Infection"},{"arc":[[37.374783,127.131108],[37.4599990844727,126.949996948242]],"countries":["South Korea"],"title":"Comparison of viral infection in healthcare- associated pneumonia (HCAP) and community-acquired pneumonia (CAP)"},{"arc":[[31.2378044128418,121.373092651367],[27.9949207305908,120.69938659668]],"countries":["China"],"title":"BMC Infectious Diseases Retrospective analysis of nosocomial infections in the intensive care unit of a tertiary hospital in China during 2003 and 2007"},{"arc":[[27.9949207305908,120.69938659668],[27.9949207305908,120.69938659668]],"countries":["China"],"title":"BMC Infectious Diseases Retrospective analysis of nosocomial infections in the intensive care unit of a tertiary hospital in China during 2003 and 2007"},{"arc":[[30.6250877380371,102.697288513184],[41.7278709411621,44.764778137207]],"countries":["Georgia","China"],"title":"Host Cell Vimentin Restrains Toxoplasma gondii Invasion and Phosphorylation of Vimentin is Partially Regulated by Interaction with TgROP18"},{"arc":[[41.7278709411621,44.764778137207],[30.5363693237305,114.365432739258]],"countries":["Georgia","China"],"title":"Human Enterovirus Nonstructural Protein 2C ATPase Functions as Both an RNA Helicase and ATP-Independent RNA Chaperone"},{"arc":[[43.0004272460938,-78.7892456054688],[40.9142990112305,-73.1162109375]],"countries":["United States"],"title":"Identification of Ebola Virus Inhibitors Targeting GP2 Using Principles of Molecular Mimicry"},{"arc":[[51.6088218688965,-3.98343992233276],[53.403148651123,-2.96319007873535]],"countries":["United Kingdom"],"title":"Distinct spread of DNA and RNA viruses among mammals amid prominent role of domestic species"},{"arc":[[30.6127891540527,-96.339599609375],[39.9530487060547,-75.1940231323242]],"countries":["United States"],"title":"Terpene metabolic engineering via nuclear or chloroplast genomes profoundly and globally impacts off-target pathways through metabolite signalling"},{"arc":[[51.514720916748,-0.124721996486187],[43.6486892700195,-79.3854370117188]],"countries":["United Kingdom","Canada"],"title":"The human coronavirus HCoV-229E S-protein structure and receptor binding"},{"arc":[[51.514720916748,-0.124721996486187],[53.0078887939453,-70.9957275390625]],"countries":["United Kingdom","Canada"],"title":"The human coronavirus HCoV-229E S-protein structure and receptor binding"},{"arc":[[43.6486892700195,-79.3854370117188],[53.0078887939453,-70.9957275390625]],"countries":["Canada"],"title":"The human coronavirus HCoV-229E S-protein structure and receptor binding"},{"arc":[[-69.1330032348633,-63.6669998168945],[37.8056831359863,-122.268104553223]],"countries":["Argentina","United States"],"title":"Adaptation in protein fitness landscapes is facilitated by indirect paths"},{"arc":[[22.2802925109863,114.142951965332],[39.2523498535156,-76.709716796875]],"countries":["Hong Kong SAR","United States"],"title":"CoVDB: a comprehensive database for comparative analysis of coronavirus genes and genomes"},{"arc":[[30.2783069610596,-97.7634506225586],[30.2787208557129,-97.7324523925781]],"countries":["United States"],"title":"Direct nucleic acid analysis of mosquitoes for high fidelity species identification and 1 detection of Wolbachia using a cellphone 2 3"},{"arc":[[30.2783069610596,-97.7634506225586],[29.3106803894043,-94.7768173217773]],"countries":["United States"],"title":"Direct nucleic acid analysis of mosquitoes for high fidelity species identification and 1 detection of Wolbachia using a cellphone 2 3"},{"arc":[[30.2787208557129,-97.7324523925781],[29.3106803894043,-94.7768173217773]],"countries":["United States"],"title":"Direct nucleic acid analysis of mosquitoes for high fidelity species identification and 1 detection of Wolbachia using a cellphone 2 3"},{"arc":[[35.7868995666504,-93.9436416625977],[37.7633209228516,-122.458541870117]],"countries":["United States"],"title":"Systematic reviews Lessons learnt from implementation of the International Health Regulations: a systematic review"},{"arc":[[35.7868995666504,-93.9436416625977],[39.9530487060547,-75.1940231323242]],"countries":["United States"],"title":"Systematic reviews Lessons learnt from implementation of the International Health Regulations: a systematic review"},{"arc":[[35.7868995666504,-93.9436416625977],[-33.9339714050293,18.865119934082]],"countries":["United States","South Africa"],"title":"Systematic reviews Lessons learnt from implementation of the International Health Regulations: a systematic review"},{"arc":[[35.7868995666504,-93.9436416625977],[35.7868995666504,-93.9436416625977]],"countries":["United States"],"title":"Systematic reviews Lessons learnt from implementation of the International Health Regulations: a systematic review"},{"arc":[[37.7633209228516,-122.458541870117],[39.9530487060547,-75.1940231323242]],"countries":["United States"],"title":"Systematic reviews Lessons learnt from implementation of the International Health Regulations: a systematic review"},{"arc":[[37.7633209228516,-122.458541870117],[-33.9339714050293,18.865119934082]],"countries":["South Africa","United States"],"title":"Systematic reviews Lessons learnt from implementation of the International Health Regulations: a systematic review"},{"arc":[[37.7633209228516,-122.458541870117],[35.7868995666504,-93.9436416625977]],"countries":["United States"],"title":"Systematic reviews Lessons learnt from implementation of the International Health Regulations: a systematic review"},{"arc":[[39.9530487060547,-75.1940231323242],[-33.9339714050293,18.865119934082]],"countries":["United States","South Africa"],"title":"Systematic reviews Lessons learnt from implementation of the International Health Regulations: a systematic review"},{"arc":[[39.9530487060547,-75.1940231323242],[35.7868995666504,-93.9436416625977]],"countries":["United States"],"title":"Systematic reviews Lessons learnt from implementation of the International Health Regulations: a systematic review"},{"arc":[[-33.9339714050293,18.865119934082],[35.7868995666504,-93.9436416625977]],"countries":["United States","South Africa"],"title":"Systematic reviews Lessons learnt from implementation of the International Health Regulations: a systematic review"},{"arc":[[-34.9022216796875,-56.1768188476562],[-34.9022216796875,-56.1768188476562]],"countries":["Uruguay"],"title":"Fasciola hepatica glycoconjugates immuneregulate dendritic cells through the Dendritic Cell-Specific Intercellular adhesion molecule-3- Grabbing Non-integrin inducing T cell anergy OPEN"},{"arc":[[-34.9022216796875,-56.1768188476562],[52.3348197937012,4.86644983291626]],"countries":["Uruguay","Netherlands"],"title":"Fasciola hepatica glycoconjugates immuneregulate dendritic cells through the Dendritic Cell-Specific Intercellular adhesion molecule-3- Grabbing Non-integrin inducing T cell anergy OPEN"},{"arc":[[41.6386985778809,-0.898090004920959],[39.008129119873,-75.4674682617188]],"countries":["United States","Spain"],"title":"NOTE Reliability of clinical diagnosis and laboratory testing techniques currently used for identification of canine parvovirus enteritis in clinical settings"},{"arc":[[45.467960357666,9.1817798614502],[43.0953407287598,12.5024099349976]],"countries":["Italy"],"title":"Open Access SHORT REPORT Collection by trained pediatricians or parents of mid-turbinate nasal flocked swabs for the detection of influenza viruses in childhood"},{"arc":[[48.5444183349609,12.1591682434082],[40.6412315368652,-8.65390968322754]],"countries":["Germany","Portugal"],"title":"molecules Recyclable Keggin Heteropolyacids as an Environmentally Benign Catalyst for the Synthesis of New 2-Benzoylamino-N-phenyl-benzamide Derivatives under Microwave Irradiations at Solvent-Free Conditions and the Evaluation of Biological Activity"},{"arc":[[35.7868995666504,-93.9436416625977],[43.6486892700195,-79.3854370117188]],"countries":["United States","Canada"],"title":"Treatment of Middle East respiratory syndrome with a combination of lopinavir/ ritonavir and interferon-1b (MIRACLE trial): statistical analysis plan for a recursive two- stage group sequential randomized controlled trial"},{"arc":[[33.5059394836426,-86.799560546875],[51.4570693969727,-2.60121011734009]],"countries":["United States","United Kingdom"],"title":"Virus taxonomy: the database of the International Committee on Taxonomy of Viruses (ICTV)"},{"arc":[[33.5059394836426,-86.799560546875],[55.8721008300781,-4.28659009933472]],"countries":["United Kingdom","United States"],"title":"Virus taxonomy: the database of the International Committee on Taxonomy of Viruses (ICTV)"},{"arc":[[33.5059394836426,-86.799560546875],[51.7589988708496,-1.26400005817413]],"countries":["United Kingdom","United States"],"title":"Virus taxonomy: the database of the International Committee on Taxonomy of Viruses (ICTV)"},{"arc":[[51.4570693969727,-2.60121011734009],[55.8721008300781,-4.28659009933472]],"countries":["United Kingdom"],"title":"Virus taxonomy: the database of the International Committee on Taxonomy of Viruses (ICTV)"},{"arc":[[51.4570693969727,-2.60121011734009],[51.7589988708496,-1.26400005817413]],"countries":["United Kingdom"],"title":"Virus taxonomy: the database of the International Committee on Taxonomy of Viruses (ICTV)"},{"arc":[[55.8721008300781,-4.28659009933472],[51.7589988708496,-1.26400005817413]],"countries":["United Kingdom"],"title":"Virus taxonomy: the database of the International Committee on Taxonomy of Viruses (ICTV)"},{"arc":[[51.378589630127,-2.32512998580933],[50.3743896484375,-4.13887977600098]],"countries":["United Kingdom"],"title":"Web GIS in practice III: creating a simple interactive map of England's Strategic Health Authorities using Google Maps API, Google Earth KML, and MSN Virtual Earth Map Control"},{"arc":[[51.0766296386719,-114.13208770752],[52.9340705871582,-1.20404005050659]],"countries":["United Kingdom","Canada"],"title":"A questionnaire-based survey on the uptake and use of cattle vaccines in the UK"},{"arc":[[37.8056831359863,-122.268104553223],[29.649730682373,-82.3411331176758]],"countries":["United States"],"title":"The Rational Design of Therapeutic Peptides for Aminopeptidase N using a Substrate-Based Approach OPEN"},{"arc":[[37.8056831359863,-122.268104553223],[44.9734497070312,-93.2378997802734]],"countries":["United States"],"title":"The Rational Design of Therapeutic Peptides for Aminopeptidase N using a Substrate-Based Approach OPEN"},{"arc":[[37.8056831359863,-122.268104553223],[41.3144607543945,-72.9232711791992]],"countries":["United States"],"title":"The Rational Design of Therapeutic Peptides for Aminopeptidase N using a Substrate-Based Approach OPEN"},{"arc":[[29.649730682373,-82.3411331176758],[44.9734497070312,-93.2378997802734]],"countries":["United States"],"title":"The Rational Design of Therapeutic Peptides for Aminopeptidase N using a Substrate-Based Approach OPEN"},{"arc":[[29.649730682373,-82.3411331176758],[41.3144607543945,-72.9232711791992]],"countries":["United States"],"title":"The Rational Design of Therapeutic Peptides for Aminopeptidase N using a Substrate-Based Approach OPEN"},{"arc":[[44.9734497070312,-93.2378997802734],[44.9734497070312,-93.2378997802734]],"countries":["United States"],"title":"The Rational Design of Therapeutic Peptides for Aminopeptidase N using a Substrate-Based Approach OPEN"},{"arc":[[44.9734497070312,-93.2378997802734],[41.3144607543945,-72.9232711791992]],"countries":["United States"],"title":"The Rational Design of Therapeutic Peptides for Aminopeptidase N using a Substrate-Based Approach OPEN"},{"arc":[[40.0039215087891,-105.26683807373],[30.2783069610596,-97.7634506225586]],"countries":["United States"],"title":"XRN1 Is a Species-SpecificVirus Restriction Factor in Yeasts"},{"arc":[[33.9571990966797,-83.3740615844727],[26.7066898345947,88.3561019897461]],"countries":["United States","India"],"title":"Protective Population Behavior Change in Outbreaks of Emerging Infectious Disease 1 2"},{"arc":[[8.46434020996094,4.60087013244629],[38.987850189209,-76.9389038085938]],"countries":["Nigeria","United States"],"title":"Lay media reporting of monkeypox in Nigeria Handling editor Seye Abimbola"},{"arc":[[38.987850189209,-76.9389038085938],[29.7095108032227,-95.3981781005859]],"countries":["United States"],"title":"Enterovirus D-68 Infection, Prophylaxis, and Vaccination in a Novel Permissive Animal Model, the Cotton Rat (Sigmodon hispidus)"},{"arc":[[35.9053153991699,-79.0477142333984],[35.9053153991699,-79.0477142333984]],"countries":["United States"],"title":"MAVS-Mediated Apoptosis and Its Inhibition by Viral Proteins"},{"arc":[[35.9053153991699,-79.0477142333984],[32.8126068115234,-96.8384094238281]],"countries":["United States"],"title":"MAVS-Mediated Apoptosis and Its Inhibition by Viral Proteins"},{"arc":[[45.4067916870117,11.8769426345825],[45.186767578125,9.15610694885254]],"countries":["Italy"],"title":"Synthesis, Binding and Antiviral Properties of Potent Core-Extended Naphthalene Diimides Targeting the HIV-1 Long Terminal Repeat Promoter G-Quadruplexes"},{"arc":[[32.8126068115234,-96.8384094238281],[32.8126068115234,-96.8384094238281]],"countries":["United States"],"title":"The IFN response in bat cells consists of canonical and non-canonical ISGs with unique temporal expression kinetics"},{"arc":[[29.7095108032227,-95.3981781005859],[40.9437103271484,40.2619209289551]],"countries":["Turkey","United States"],"title":" 2 -Adrenergic receptor promoter haplotype influences the severity of acute viral respiratory tract infection during infancy: a prospective cohort study"}]